John E. Hall

Chair

Department:
SOM-Physiology & Biophysics

Email:
jehall@umc.edu

Work Phone:
(601) 984-1801

Education

Michigan State University, PhD, Physiology	1974
U.S. Army, Military Service, Electronics/ Engineering	1970
Kent State University, BS, Biology/Chemistry	1968
Smithville High School, High School Diploma, General	1964

Current Positions

Founding Director, Mississippi Center for Obesity Research, School of Medicine	07/2013 - Present
Arthur C. Guyton Professor and Chair, School of Medicine, Department of Physiology And Biophysics	1989 - Present
Professor, School of Medicine, Department of Physiology And Biophysics	1982 - Present
Member of Graduate Faculty, School of Medicine, Department of Physiology And Biophysics	1977 - Present
The University of Mississippi Medical Center Jackson, Mississippi 39216

Academic Appointments or Other Previous Appointments

Associate Vice Chancellor for Research, University of Mississippi Medical Center, School of Medicine	2005 - 06/2013
Founding Director, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics	1996 - 2009
Vice-Chairman, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics	1988 - 1989
Director of Graduate Program, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics	1980 - 1993
Associate Professor, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics	1979 - 1982
Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics	1976 - 1979
Instructor, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics	1975 - 1976
Postdoctoral Fellow, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics	1974 - 1976
Graduate Teaching Assistant, Michigan State University, School of Graduate, Department of Physiology And Biophysics	1973 - 1974
Graduate Student, Michigan State University, School of Graduate, Department of Physiology And Biophysics	1970 - 1973

Publications

Biography
Hall JE Remembering Arthur C. Guyton, MD J Miss State Med Assoc, 150th Commemorative Edition 2018; 59: 526-531.	2018
Journal Article
Jones DW, Hall JE. Racial and ethnic differences in blood pressure: biology and sociology Circulation. 2006; 114:2757-2759	2006
Liu J, daSilva AA, Tallam L, Hall JE. Chronic central nervous system hyperinsulinemia and regulation of arterial presure and food intake J Hypertension. 2006; 24:1391-1395	2006
daSilva AA, Tallam LS, Liu J, Hall JE. Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity Am J Physiol Regul Integr Comp Physiol. 2006; 291:1275-1282	2006
Tallam LS, da Silva AA, Hall JE. The melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin Hypertension. 2006; 48:58-64	2006
Hall JE. Obesity, adipokines and hypertension J. Hypertension. 2006; 24 (Suppl. 6): 12-13	2006
daSilva AA, Kuo JJ, Tallam LS, Liu J, Hall JE. Does dietary-induced obesity induce “resistance” to the long-term cardiovascular and metabolic actions of hypothalamic melanocortin 3/4 receptor activation? Hypertension. 2006; 47:259-264	2005
Tallam LS, Stec DE, Willis MA, daSilva AA, Hall JE. Melanocortin-4 receptor deficient mice are not hypertensive or salt-sensitive despite obesity, insulin resistance and hypertleptinemia Hypertension. 2005; 46:326-332	2005
Vachharajani VT, Russsell JM, Scott KL, Conrad S, Stokes KY, Tallam L, Hall JE, Granger DN. Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain Microcirculation. 2005; 12:183-194	2005
Gu JW, Fortepiani L, Reckelhoff JF, Adair TH, Wang J, Hall JE. Increased vascular endothelial growth factor and capillary density in hearts of spontaneously hypertensive rats Microcirculation. 2004; 11:689-697	2004
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz TW, Sheps SG, Roccella EJ. Recommendations for measuring blood pressure in humans and animals. Part 1. Blood pressure measurement in humans Hypertension. 2005; 45:142-161	2004
Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for measuring blood pressure in humans and animals. Part 2. Blood pressure measurement in animals Hypertension. 2005; 45:299-310	2004
Tallam LS, Kuo JJ, daSilva AA, Hall JE. Cardiovascular, renal and metabolic responses to chronic central administration of agouti related peptide Hypertension. 2004; 44:853-858	2004
Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension Curr Pharm Des. 2004; 10:3621-3637	2004
Gu JW, Wang J, Stockton A, Lokitz B, Henegar L, Hall JE. Cytokine gene expression profiles in kidney medulla and cortex of obese hypertensive dogs Kidney Int. 2004; 66:713-721	2004
Philip-Couderc P, Smih F, Hall JE, Patul A, Roncalli J, Massabuau P, Galinier M, Senard JM, Rouet P Kinetic analysis of cardiac transcriptome regulation during chronic high fat diet in dogs Physiol Genomics. 2004; 19:32-40	2004
Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? Am J Physiol. 2004; 286:R803-R813	2004
da Silva AA, Kuo JJ, Hall JE. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal and metabolic actions of leptin Hypertension. 2004; 43:1312-1317	2004
Salahudeen AK, Fleischmann EH, Bower JD, Hall JE. Underweight rather than overweight is associated with higher prevalence of hypertension: BP vs BMI in haemodialysis population Nephrol Dial Transplant. 2004; 19:427-432	2004
Hall JE, Henegar JR, Dwyer TM, Liu J, da Silva AA, Kuo JJ, Tallam L. Is obesity a major cause of chronic renal disease? Adv Ren Replacement Ther. 2004; 11:41-54	2004
Kuo JJ, da Silva AA, Tallam LS, Hall JE. Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation Hypertension. 2004; 43:370-375	2004
da Silva AA, Kuo JJ, Tallam LS, Hall JE. Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension Hypertension. 2004; 43:383-387	2004
DePaula RB, daSilva AA, Hall JE. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration Hypertension. 2004; 43:41-47	2003
Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam L, Liu J. Impact of the obesity epidemic on hypertension and kidney disease Curr Hypertens Rep. 2003; 5:386-392	2003
Hall JE. Historical perspective of the renin-angiotensin system Mol Biotechnol. 2003; 24:27-39	2003
Kuo JJ, Jones OB, Hall JE. Chronic cardiovascular and renal actions of leptin during hyperinsulinemia Am J Physiol. 2003; 284:R1037-R1042	2003
Hall JE, Kuo JJ, da Silva A, DePaula R, Liu J, Tallam L. Obesity-associated hypertension and kidney disease Curr Opin Nephrol Hypertens. 2003; 12:195-200	2003
Hall JE. The kidney, obesity, and hypertension Hypertension. 2003; 41:625-633	2003
Kuo JJ, Silva AA, Hall JE. Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function Hypertension. 2003; 41:768-774	2002
Hall JE, Crook ED, Dubbert PM, Jones DW, Wofford MR. Mechanisms of obesity-associated cardiovascular and renal disease Am J Med Sci. 2002; 324:127-137	2002
Dubbert PM, Carithers T, Sumner AE, Barbour K, Clark B, Hall JE, Crook ED. Obesity, physical inactivity, and risk for cardiovascular disease Am J Med Sci. 2002; 324:116-126	2002
Crook ED, Flack JM, Salem M, Salahudeen AK, Hall JE. Primary renal disease as a cardiovascular risk factor Am J Med Sci. 2002; 324:138-145	2002
Hall JE, Jones DW What can we do about the "epidemic" of obesity? Am J Hypertens. 2002; 15:657-659	2002
Carlyle ME, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity Hypertension. 2002; 39:496-501	2002
Fitzgerald SM, Hall JE, Brands MW. Rapid hypotensive response to fasting in spontaneously hypertensive rats Am J Hypertension. 2001; 14:1123-1127	2001
Hall JE. The promise of translational physiology Am J Physiol. 2001; 281:C1411-C1412	2001
Fitzgerald SM, Henegar JR, Brands MW, Henegar LK, Hall JE. Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats Am J Physiol. 2001; 281:R547-R552	2001
Wofford, MR, Anderson DC, Brown CA, Jones DW, Miller ME, Hall JE. Antihypertensive effect of α and β blockade in obese and lean hypertensive subjects Am J Hypertens. 2001; 14:694-698	2001
Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity J Am Soc Nephrol. 2001; 12:1211-1217	2001
Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension – role of leptin and sympathetic nervous system Am J Hypertens. 2001; 14:103s-115s	2001
Kuo J, Jones OB, Hall JE. Inhibition of NO enhances the cardiovascular and renal actions of leptin Hypertension. 2001; 37:670-676	2001
Dwyer TM, Banks SA, Alonso-Galicia M, Cockrell K, Carroll JF, Bigler SA, Hall JE. Distribution of renal medullary hyaluronan in lean and obese rabbits Kidney Int. 2000; 58:721-729	2000
Dwyer TM, Bigler SA, Moore NA, Carroll JF, Hall JE. The altered structure of renal papillary outflow tracts in obesity Ultrastruct Pathol. 2000; 24:251-257	2000
Hall JE, Brands MW, Hildebrandt DA, Kuo J, Fitzgerald S. Role of the sympathetic nervous system and neuropeptides in obesity hypertension Braz J Med Biol Res. 2000; 33:605-618	2000
Hall JE. Pathophysiology of obesity hypertension Curr Hypertens Rep. 2000; 2:139-147	2000
Hall JE. Integration and regulation of cardiovascular function Am J Physiol. 1999; 22:s174-s186	1999
Hall JE, Brands MW, Henegar JR. Mechanisms of hypertension and kidney disease in obesity Ann N Y Acad Sci. 1999; 892:91-107	1999
Khalil RA, Crews JK, Carroll JF, Hall JE. Enhanced vascular reactivity and Ca2+ entry with low salt diet. Effect of obesity Hypertension. 1999; 34:882-888	1999
Hall JE, Shek EW, Brands MW. Does leptin contribute to obesity hypertension? Curr Opin Endocrinol Diab. 1999; 6:225-229	1999
Hall JE. Angiotensin II and long-term arterial pressure regualation: the overriding dominance of the kidney J Am Soc Nephrol. 1999; 10 (Suppl 12):s258-s265	1999
Hildebrandt DA, Smith MJ Jr., Hall JE. Cardiovascular regulation during insulin infusion into the carotid or vertebral artery in dogs J Hypertens. 1999; 17:251-260	1999
Hall JE. Renal mechanisms of obesity hypertension and relevance to essential hypertension Therapeutic Research. 1999; 20:78-91	1999
Brands MW, Hall JE. Renal perfusion pressure is an important determinant of sodium and calcium excretion in DOC-salt hypertension Am J Hypertens. 1998; 11:1199-1207	1998
Keen HL, Brands MW, Smith Jr. MJ, Hall JE. Maintenance of baseline angiotensin II potentiates insulin hypertension in rats Hypertension. 1998; 31:637-642	1998
Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure Hypertension. 1998; 31:409-414	1998
Hall JE. Sodium and hypertension: Physiology Proc Nat Kid Found., Clin Nephrol. 1998; 105-106	1998
Hall JE, Brands MW, Henegar JR, Skek EW-M Abnormal kidney function as a cause and a consequence of obesity hypertension Clin Exp Pharmacol Physiol. 1998; 25:65-69	1998
Brands MW, Hall JE, Keen HL Is insulin resistance linked to hypertension? Clin Exp Pharmacol Physiol. 1998; 25:70-76	1998
Keen HL, Brands MW, Smith MJ Jr., Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin-hypertension in rats Am J Hypertens. 1997; 10:1125-1131	1997
Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension Am J Hypertens. 1997; 10:49s-55s	1997
Rust OA, Bofill JA, Magann EF, Zappe DH, Hall JE, Burnett JC, Martin JA. The origin of endothelin in patients with severe peeeclampsia Obstet Gynecol. 1997; 89:754-757	1997
Summers RL, Montani JP, Woodward LH, Coleman TG, Hall JE. Theoretical analysis of the mechanisms of hyperinsulinemia Comput Biol Med. 1997; 27:249-256	1997
Hall WD, Ferrario CM, Moore MA, Hall JE, Flack JM, Cooper W, Simmons JD, Egan BM, Lackland DT, Perry M Jr, Roccella EJ. Hypertension related morbidity and mortality in the Southeastern United States Am J Med Sci. 1997; 313:195-209	1997
Brands MW, Harrison DL, Keen HL, Gardner A, Shek EW, Hall JE. Insulin-induced hypertension in rats depends on an intact renin-angiotensin system Hypertension. 1997; 29:1014-1019	1997
Keen HL, Brands MW, Smith MJ Jr, Shek EW, Hall JE. Thromboxane is required for full expression of angiotensin hypertension in rats Hypertension. 1997; 29:310-314	1997
Keen H L, Brands MW, Alonso-Galacia M, Hall JE. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats Am J Hypertens. 1996; 9:1192-1199	1996
Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats: Role of angiotensin II and adrenergic activity Hypertension. 1996; 28:1047-1054	1996
Hall JE, Zappe DH, Alonso-Galicia M, Granger JP, Brands MW, Kassab SE. Mechanisms of obesity-induced hypertension News Physiol Sci. 1996; 11:255-261	1996
Hall JE, Brands MW, Shek E. Central role of the kidneys and abnormal fluid volume control in hypertension J Hum Hypertens. 1996; 10:633-639	1996
Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin-hypertension in Sprague-Dawley rats Am J Physiol. 1996; 271:R276-R281	1996
Summers RL, Woodward LH, Sanders DY, Hall JE. Graphical analysis for the study of metabolic states Advan Physiol Educ. 1996; 270:s81-s87	1996
Hall JE, Brands MW, Zappe DH, Alonso-Galicia M. Cardiovascular actions of insulin: Are they important in long-term blood pressure regulation? Clin Exp Pharmacol. 1995; 22:689-700	1995
Van Vliet BN, Hall JE, Mizelle LH, Montani JP, Smith Jr. MJ. Reduced parasympathetic control of heart rate in obese dogs Am J Physiol. 1995; 269:H629-H637	1995
Hall JE, Brands MW, Zappe DH, Granger JP, Kassab S, Alonso-Galicia M , Keen H. Pathophysiology of obesity associated hypertension J Hypertension. 1995; 2 (Suppl 2): s3-s13	1995
Brands MW, Hall JE, Van Vliet BN, Alonso-Galicia M., Herrera GA, Zappe DH. Obesity and hypertension: Roles of hyperinsulinemia, sympathetic nervous system, and intrarenal mechanisms J Nutr. 1995; 125:1725s-1731s	1995
Hall JE, Brands MW, Zappe DH, Dixon WN, Mizelle HL, Reinhart, Hildebrandt DA. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin resistant dogs Hypertension. 1995; 25:994-1002	1995
Alonso-Galicia M, Dwyer TM, Herrera GA, Hall JE. Increased hyaluronic acid in the inner medulla of obese dogs Hypertension. 1995; 25:888-892	1995
Hall JE, Brands MW, Zappe DH, Alonso-Galicia M. Insulin resistance, hyperinsulinemia and hypertension: Causes, consequences, or merely correlations? Proc Soc Exp Biol Med. 1995; 208:317-329	1995
Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity Hypertension. 1995; 25:893-897	1995
Hall JE, Summers RL, Keen H, Brands MW, Alonso-Galicia M. Insulin resistance and its role in hypertension Am J Hypertens. 1994; 7:772-788	1994
Hall JE. Louis K. Dahl memorial lecture. Renal and cardiovascular mechanisms of hypertension in obesity Hypertension. 1994; 23:381-394	1994
Hall JE, Brands MW, Zappe DH, Keen H, Alonso-Galicia M. The insulin hypothesis of hypertension-experimental evidence J Hypertens. 1994; Ed. Esp 1 (Suppl. 1): S3-S13	1994
Brands MW, Garrity CA, Holman MG, Hall JE. Exaggerated pressor and chronotropic responses to chronic hyperinsulinemia in SH and WKY rats Am J Hypertens. 1994; 7:75-81	1994
Brands MW, Garrity CA, Holman MG, Hall JE. High fructose diet does not raise 24 hour mean arterial pressure in rats Am J Hypertens. 1994; 7:104-109	1994
Hall JE, Brands MW, Dixon WN, Smith Jr. MJ. Obesity-induced hypertension: Renal function and systemic hemodynamics Hypertension. 1993; 22:292-299	1993
Mizelle HL, Montani JP, Hester RL, Didlake RH, Hall JE. Role of pressure natriuresis in long-term control of renal electrolyte excretion Hypertension. 1993; 22:102-110	1993
Hall JE. Hyperinsulinemia: A link between obesity and hypertension? Kidney Int. 1993; 43:1402-1417	1993
Brands MW, Alonso- Galicia M, Mizelle HL, Hildebrandt DA, Hall JE. Chronic angiotensin converting enzyme inhibition improves cardiac output and fluid balance during heart failure Am J Physiol. 1993; 264:R414-R422	1993
Brands MW, Hall JE. Insulin resistance, hyperinsulinemia, and obesity- associated hypertension J Am Soc Nephrol. 1992; 3:1064-1077	1992
Hildebrandt DA, Mizelle HL, Brands MW, and Hall JE. Comparison of renal actions of urodilation and atrial natriuretic peptide Am J Physiol. 1992; 262:R395-R399	1992
Hall JE. Kidney function and hypertension Japan J Appl Physiol. 1992; 22(Suppl.):59-60	1992
Hall JE, Brands MW. Obesity-associated hypertension: Role of insulin and renal mechanisms Spectrum der Nephrologie. 1992;8: 3-12	1992
Brands, MW, Hildebrandt DA, Mizelle HL, Hall JE. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive Hypertension. 1992; 19 (Suppl. I): I83-I89	1992
Mizelle HL, Gaillard CA, Manning RD, Hall JE. Mechanism of decreased cardiac output during ANP infusion in conscious anephric dogs Am J Physiol. 1992; 262:R120-R125	1992
Hall JE, Brands MW, Hildebrandt DA, Mizelle HL. Obesity-associated hypertension: Hyperinsulinemia and renal mechanisms Hypertension. 1992; 19 (Suppl I):I45-I55	1992
Hall JE, Mizelle HL, Brands MW, Hildebrandt DA. Pressure natriuresis and angiotensin II in reduced kidney mass- salt induced hypertension Am J Physiol. 1992; 262:R61-R71	1992
Hall JE. Renal function in one-kidney, one-clip hypertension and low renin essential hypertension Am J Hypertens. 1991; 4 (10 Pt 2):523s-533s	1991
Hall JE. Control of blood pressure by the renin-angiotensin-aldosterone system Clin Cardiol. 1991; 14 (Suppl. 4): 6-21	1991
Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Chronic intrarenal hyperinsulinemia does not cause hypertension Am J Physiol. 1991; 260:F663-F669	1991
Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats Am J Physiol. 1991; 260:R764-R768	1991
Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. The hemodynamic response to chronic hyperinsulinemia in conscious dogs Am J Hyper. 1991; 4:164-168	1991
Gaillard CA, Mizelle HL, Montani JP, Brands MW, Hildebrandt DA, Hall JE. Atrial natriuretic factor and blood pressure control: Role of sodium and aldosterone Am J Physiol. 1990; 259:R973-R980	1990
Hildebrandt DA, Mizelle HL, Brands MW, Gaillard CA, Smith Jr. MJ, Hall JE. Intrarenal atrial natriuretic peptide infusion lowers arterial pressure chronically Am J Physiol. 1990; 259:R585-R592	1990
Hildebrandt DA, Mizelle HL, Brands MW, Gaillard CA, Smith MJ Jr, Hall JE. Intrarenal atrial natriuretic peptide infusion lowers arterial pressure chronically Am J Physiol. 1990; 259:R585-R592	1990
Hall JE, Mizelle HL, Hildebrandt DA, Brands MW. Abnormal pressure natriuresis: A cause or a consequence of hypertension? Hypertension. 1990; 15:547-559	1990
Mizelle HL, Hildebrandt DA, Gaillard CA, Brands MW, Montani JP, Smith Jr. MJ, Hall JE. Atrial natriuretic peptide induces sustained natriuresis in conscious dogs Am J Physiol. 1990; 258:R1445-R1452	1990
Hall JE, Brands MW, Mizelle HL, Kivlighn SD, Hildebrandt DA, Gaillard CA. Chronic hyperinsulinemia and blood pressure: Interactions with catecholamines? Hypertension. 1990; 15:519-527	1990
Hall JE, Mizelle HL. Control of arterial pressure and renal function during chronic renin inhibition J Hypertens. 1990; 8:352-360	1990
Hall JE, Coleman TG, Mizelle HL, Smith Jr. MJ. Chronic hyperinsulinemia and blood pressure regulation Am J Physiol. 1990; 258:F722-F731	1990
Hall JE, Guyton AC, Mizelle HL. Role of the renin-angiotensin system in control of sodium excretion and arterial pressure Acta Physiologica-Scandinavia. 1990; 139 (Suppl. 591): 48-62	1990
Mizelle HL, Hall JE, Hildebrandt DA. Atrial natriuretic peptide and pressure natriuresis: Interactions with angiotensin Am J Physiol. 1989; 257:R1169-R1174	1989
Hall JE. Intrarenal actions of converting enzyme inhibitors Am J Hypertens. 1989; 2:875-884	1989
Hall JE, Coleman TG, Guyton AC. The renin-angiotensin system: Normal physiology and changes in older hypertensives J Am Geriatr Soc. 1989; 37: 801-813	1989
Mizelle HL, Hall JE, Montani JP. Role of renal nerves in control of sodium excretion during chronic congestive heart failure Am J Physiol. 1989; 256:F1084-F1093	1989
Hall JE, Coleman TG, Mizelle HL. Does Chronic Hyperinsulinemia Cause Hypertension? Am J Hyper. 1989; 2:171-173	1989
Woods LL, Mizelle HL, Hall JE. Control of sodium excretion in NE-ACTH hypertension: Role of pressure natriuresis Am J Physiol. 1988; 255:R894-R900	1988
Mizelle HL, Hall JE, Woods LL. Interactions between angiotensin II and the renal nerves during chronic sodium deprivation Am J Physiol. 1988; 255:F823-F827	1988
Hall JE, Mizelle HL, Montani JP, Woods LL. Pressure natriuresis and control of arterial pressure during chronic norepinephrine infusion J Hypertens. 1988; 6:723-732	1988
Guyton AC, Montani JP, Hall JE, Manning Jr. RD. Computer models for designing hypertension experiments and studying concepts Am J Med Sci. 1988; 295:320-326	1988
Guyton AC, Hall JE, Montani JP. Kidney function and hypertension Acta Physiologica Scandinavica. 1988; 133 (Suppl. 571): 163-173	1988
Woods LL, Mizelle HL, Hall JE. Role of the liver in renal hemodynamic response to amino acid infusion Am J Physiol. 1987; 252:F981-F985	1987
Olsen ME, Hall JE, Montani JP, Cornell JE. Interaction with renal prostaglandins and angiotensin II in controlling glomerular filtration in the dog Clin Sci. 1987; 72:429-436	1987
Mizelle HL, Hall JE, Woods LL, Montani JP. Role of renal nerves in compensatory adaptation to chronic reductions in sodium intake Am J Physiol. 1987; 252:F291-F298	1987
Woods LL, Mizelle HL, Hall, JE. Autoregulation of renal blood flow and glomerular filtration rate in the pregnant rabbit Am J Physiol. 1987; 252:F69-F72	1987
Woods LL, Mizelle Hl, Hall JE. Control of renal hemodynamics in hyperglycemia: Possible role of tubuloglomerular feedback Am J Physiol. 1987; 252:F65-F73	1987
Hall JE, Guyton AC, Coleman TG, Mizelle HL, Woods LL. Regulation of arterial pressure: Role of pressure natriuresis and diuresis Fed Proc. 1986; 45: 2897-2903	1986
Guyton AC, Manning Jr. RD, Norman Jr. RA, Montani JP, Lohmeier TE, Hall JE. Current concepts and perspectives of renal volume regulation in relationship to hypertension J Hypertens. 1986; 4(Suppl. 4):S49-S56	1986
Hall JE, Granger JP, Hester RL, Montani JP. Mechanisms of sodium balance in hypertension: Role of pressure natriuresis J Hypertens. 1986; 4(Suppl. 4):S57-S65	1986
Woods LL, Mizelle HL, Montani JP, Hall JE. Mechanisms controlling renal hemodynamics and electrolyte excretion during amino acids Am J Physiol. 1986; 251:F303-F312	1986
Hall JE, Mizelle HL, Woods LL. The renin-angiotensin system and long-term regulation of arterial pressure J Hypertens. 1986; 4:387-397	1986
Hall JE. Control of sodium excretion by angiotensin: Intrarenal mechanisms and blood pressure regulation Am J Physiol. 1986; 250:R960-R972	1986
Hall JE, Granger, JP. Adenosine alters glomerular filtration control by angiotensin II Am J Physiol. 1986; 250:F917-F923	1986
Hall JE, Montani JP, Woods LL, Mizelle HL. Renal escape from vasopressin: Role of pressure diuresis Am J Physiol. 1986; 250: F907-F916	1986
Hall JE. Regulation of glomerular filtration and sodium excretion by angiotensin II Fed Proc. 1986; 45:1431-1437	1986
Hall JE, Granger JP. Renal hemodynamics and arterial pressure during chronic intrarenal adenosine infusion in conscious dogs Am J Physiol. 1986; 250:F32-F39	1986
Olsen ME, Hall JE, Montani JP, Cornell JE. Protection of preglomerular vessels from angiotensin II vasoconstriction by renal prostaglandins J Hypertens. 1985; 3(Suppl 3):S255-S258	1985
Olsen ME, Hall JE, Montani JP, Guyton AC, Langford HG, Cornell JE. Mechanisms of angiotensin II natriuresis and antinatriuresis Am J Physiol. 1985; 249:F299-F307	1985
Premen AJ, Hall JE, Smith Jr. MJ. Postprandial regulation of renal hemodynamics: Role of pancreatic glucagon Am J Physiol. 1985; 248:F656-F662	1985
Hall JE, Granger JP, Hester RL. Interactions between adenosine and angiotensin II in controlling glomerular filtration Am J Physiol. 1985; 248:F340-F347	1985
Premen AJ, Hall JE, Mizelle LH, Cornell JE. Maintenance of renal autoregulation during infusion of aminophylline or adenosine Am J Physiol. 1985; 248:F366-F373	1985
Granger JP, Hall JE. Control of renal hemodynamics, electrolyte excretion, and arterial pressure during acute and chronic intrarenal infusion of bradykinin Am J Physiol. 1985; 248:F87-R92	1985
Guyton AC, Coleman TG, Manning Jr RD, Hall JE. Some problems and solutions for modeling overall cardiovascular regulation Math Biosci. 1984; 72:141-155	1984
Olsen ME, Hall JE, Montani JP, Guyton AC. Angiotensin II natriuresis and antinatriuresis: Role of renal artery pressure in anesthetized dogs J Hypertens. 1984; (Suppl 3):347-350	1984
Kastner PK, Hall JE, Guyton AC. Control of glomerular filtration rate: Role of intrarenally formed Angiotensin II Am J Physiol. 1984; 246: F897-F906	1984
Hall JE, Granger JP, Hester RL, Coleman TG, Smith Jr MJ, Cross RB. Mechanisms of escape from sodium retention during angiotensin II hypertension Am J Physiol. 1984; 246:F627-F634	1984
Hall JE, Granger JP, Smith Jr MJ, Premen AJ. Role of renal hemodynamics and arterial pressure in aldosterone "escape" Hypertension. 1984; 6(Suppl. 1) I183-I192	1984
Olsen ME, Hall JE, Montani JP, Guyton AC. Angiotensin II natriuresis and antinatriuresis-Role of renal artery pressure, renal hemodynamics, and tubular reabsorption Acta Medica Scandinavica. 1984; S693:81-88	1984
Guyton AC, Manning Jr RD, Hall JE, Young DB. Renal abnormalities that cause hypertension versus those that cause uremia Neth J Med. 1984; 27:117-123	1984
Guyton AC, Manning Jr RD, Hall JE, Norman Jr RA, Young DB, Pan YJ. The pathogenic role of the kidney J Cardiovasc Pharmacol. 1984; 6 (Suppl. 1): S151-S161	1984
Hall JE, Granger JP. Renal hemodynamic actions of angiotensin II: Interactions with tubuloglomerular feedback Am J Physiol. 1983; 245:R166-R173	1983
Hester RL, Granger JP, Williams J, Hall JE. Acute and chronic servo-control of renal perfusion pressure Am J Physiol. 1983; 244:F455-F460	1983
Navar LG, Marsh DJ, Blantz RC, Hall JE, Ploth DW, Nasjletti A. Intrinsic control of renal hemodynamics Fed Proc. 1982; 41:3022-3030	1982
Kastner PK, Hall JE, Guyton AC. Renal hemodynamic responses to increased renal venous pressure: Role of angiotensin II Am J Physiol. 1982; 243:F260-F264	1982
Hall JE, Granger JP. Mechanisms of the blood pressure and renal hemodynamic effects of captopril Am J Cardiol. 1982; 49:1527-1529	1982
Hall JE, Coleman TG, Guyton AC, Kastner PR, Granger JP. Control of glomerular filtration by circulating angiotensin II Am J Physiol. 1981; 241:R190-R197	1981
Guyton AC, Hall JE, Lohmeier TE, Jackson TE, Kastner PR. Blood pressure regulation: Basic concepts Fed Proc. 1981; 40: 2252-2256	1981
Guyton AC, Hall JE, Lohmeier TE, Jackson TE, Manning Jr RD. The Ninth J. A. F. Stevenson Memorial Lecture: The many roles of the kidney in arterial pressure control and hypertension Can J Physiol Pharmacol. 1981; 59: 513-519	1981
Hall JE, Guyton AC, Jackson TE, Kastner PR, Granger JP. Autoregulation of glomerular filtration role of angiotensin Proceedings from the Eighth International Congress of Nephrology. Symposium on Renal Hemodynamics. 1981; pp 162-169	1981
Hall JE, Guyton AC, Smith Jr. MJ, Coleman TG. Blood pressure and renal function during chronic changes in sodium intake: Role of angiotensin Am J Physiol. 1980; 239:F271-F280	1980
Hall JE, Morse CL, Smith Jr. MJ, Young DB, Guyton AC. Control of arterial pressure and renal function during glucocorticoid excess in dogs Hypertension. 1980; 2:39-148	1980
Guyton AC, Hall JE, Young DB, Lohmeier TE, Jackson TE, Kastner PR. A computer and experimental analysis of arterial pressure regulation and hypertension Cardiovasc Physiol. 1980; 8:13-27	1980
Salgado HC, Hall JE, Guyton AC. Effects of acute rehydration on renin release in conscious dogs Acta Physiologica Latino Americana. 1980; 30:73-74	1980
Hall JE, Guyton AC, Smith JR MJ, Coleman TG. Long-term regulation of arterial pressure, glomerular filtration, and renal sodium reabsorption by angiotensin II Clin Sci. 1980; 59(Suppl. 6): 87s-90s	1980
Young DB, Lohmeier TE, Hall JE, DeClue JE, Bengis RG, Coleman TG, Guyton AC. The role of the renal effects of angiotensin II in hypertension Cor Vasa. 1980; 22:49-58	1980
Hall JE, Guyton AC, Smith JR MJ, Coleman TG. Chronic blockade of angiotensin II formation during sodium deprivation Am J Physiol. 1979; 237:F424-432	1979
Hall JE, Coleman TG, Guyton AC, Balfe JW, Salgado HC. Intrarenal role of angiotensin II and [Des-Asp1] angiotensin II Am J Physiol. 1979; 236:F252-259	1979
Guyton AC, Hall JE. The juxtaglomerular complex: Its possible control of multiple nephron functions Nature. 1979; 277:601-602	1979
Hall JE, Guyton AC, Salgado HC, McCaa RE, Balfe JW. Renal hemodynamics in acute and chronic angiotensin II hypertension Am J Physiol. 1978; 235:F174-F179	1978
Guyton AC, Cowley Jr AW, Coleman TG, McCaa RE, Young DB, Hall JE. Physiological basis of blood pressure control Tribuna Medica. 1978; 38:3-11	1978
Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC. Control of glomerular filtration rate by renin-angiotensin system Am J Physiol. 1977; 233:F366-F372	1977
Lohmeier TE, Cowley Jr AW, Trippodo NC, Hall JE, Guyton AC. Effects of endogenous angiotensin II on renal sodium excretion and renal hemodynamics Am J Physiol. 1977; 233:F388-399	1977
Jackson TE, Guyton AC, Hall JE. Transient responses of glomerular filtration rate and renal blood flow to step changes in arterial pressure Am J Physiol. 1977; 233:F396-F402	1977
Hall JE, Guyton AC, Trippodo NC, Lohmeier TE, McCaa RE, Cowley Jr AW. Intrarenal control of electrolyte excretion by angiotensin II Am J Physiol. 1977; 233:F538-F544	1977
Trippodo NC, Hall JE, Lohmeier TE, Guyton AC. Intrarenal role of angiotensin II in controlling sodium excretion in dehydrated dogs Clin Sci Mol Med. 1977; 52:545-548	1977
Hall JE, Guyton AC, Cowley Jr. AW. Dissociation of renal blood flow and filtration rate autoregulation by renin depletion Am J Physiol. 1977; 232:F215-F221	1977
Guyton AC, Hall JE, Young DB, DeClue JW, Lohmeier TE, McCaa RE. Role of the kidney in the control of blood pressure Medicina. 1977; 37(SI):30-39	1977
Guyton AC, Cowley Jr. AW, Young DB, Hall JE, Lohmeier TE. The hemodynamics of hypertension Excerpta Medica. 1977; 5-21	1977
Hall JE, Guyton AC, Farr BM. A single injection method for measuring glomerular filtration rate Am J Physiol. 1977; 232:F72-F76	1977
Hall JE, Guyton AC. Changes in renal hemodynamics and renin release caused by increased plasma oncotic pressure Am J Physiol. 1976; 231:1550-1556	1976
Guyton AC, Coleman TG, Norman Jr. RA, Hall JE, Young DB. Overall circulatory control in hypertension Aust N Z J Med (Supplement 2). 1976;6:72-80	1976
Hall JE, Schwinghamer JM, Lalone B. Mechanisms of blood vessel constriction during hemorrhage Am J Physiol. 1976; 230:569-578	1976
Guyton AC, Young DB, DeClue JW, Trippodo N, Hall JE. Fluid balance, renal function, and blood pressure Clin Nephrol. 1975; 4:122-126	1975
Hall JE. Hypertension Update 2011 Hypertension. 2011; 58:975-977	2011
Hall JE. Hypertension Update 2008 Hypertension. 2008; 52:425-428	2008
Brandon EL. Cantwell L. Gu JW, Hall JE. Obesity enhances melanoma tumor growth independently of leptin FASEB J. 2007; 21:A927	2007
Jones DW, Hall JE. World Hypertension Day 2007 Hypertension. 2007; 49:939-940	2007
Hall JE. Hypertension Update 2006 Hypertension. 2006; 48:343-346	2006
Hall JE. Hypertension update -2005 Hypertension. 2005; 45:316-318	2005
Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee Arterioscler Thromb Vasc Biol. 2005; 25:478-479	2005
Hall JE. The pioneering use of systems analysis to study cardiac output regulation Am J Physiol. 2004; 287:R1009-R1011	2004
Benos DJ, Kirk KL, Hall JE. How to review a paper Adv Physiol Educ. 2003; 27:47-52	2003
Hall JE, Cowley AW Jr, Bishop VS, Granger DN, Navar LG, Taylor AE. In memoriam. Arthur C. Guyton (1919-2003) The Physiologist. 2003; 46:126-128	2003
Loscalzo J, Balaban R , Becker LB, Ginsburg GS, Hachinski VC, Hall JE, Heisted DD, Leinwald LA, Lenfant CJ, Marban E, Olson EN, Schwartz SM Task force on strategic research direction-basic science subgroup key topics report Circulation. 2002; 106:e149-e161	2002
Jones DW, Hall JE. The National High Blood Pressure Education Program: Thirty years and counting Hypertension. 2002; 39:941-942	2002
Hall JE. Hypertension – an update Hypertension. 2002; 40:115-116	2002
Hall JE. Hypertension – opportunities and challenges Hypertension. 2002; 39:1-2	2002
Hall JE. The postgenomic era – a golden age for physiologists? The Physiologist. 2001; 44:65, 74-79	2001
Hall JE. Pathophysiology of cardiorenal systems in obesity: a symposium in memory of A. Clifford Barger Clin Exper Pharm Physiol. 1998; 25:57	1998
Review Article
Hart EC, Head GA, Carter JR, Wallin BG, May CN, Hamza SM, Hall JE, Charkoudian N, Osborn JW Recording sympathetic nerve activity in conscious humans and other mammals: guidelines and the road to standardization Am J Physiol: Heart and Circulatory Physiology. 2017; 312:H1031-H1051	2017
Hall JE, Guyton AC, Brands MW. Pressure-volume regulation in hypertension Kidney Int. 1996; 49: S35-S41	1996
Hall JE. The renin-angiotensin system: Renal actions and blood pressure regulation Compr Ther. 1991; 17:8-17	1991
Abstracts
do Carmo JM, da Silva AA, Hall JE. AT1 receptor antagonism blockade but not mineralocorticoid receptor blockade lowers blood pressure in obese Zucker rats FASEB J. 2012; 26:1093.6	2012
Bassi M, Furuya WI, Nakamura NB, Columbari DS, Menani JV, Glass ML, Hall JE, Columbari E. Central mechanisms activated by leptin to modify hypercapnia-induced ventilatory responses FASEB J. 2012; 26:702.16	2012
Hamza SM, Hall JE. Direct recording of renal sympathetic nerve activity in unrestrained conscious mice FASEB J. 2012; 26:1091.46	2012
Zouein FA, Zgheib C, Hamza SM, Hall JE, Ruiz A, Juncos LA, Booz GA. Dual role of STAT3 in hypertension-induced cardiac remodeling FASEB J. 2012; 26:1060.19	2012
da Silva AA, do Carmo JM, Dubinion JH, Hall JE. Ganglionic blockade does not impair the chronic CNS-mediated antidiabetic action of leptin in streptozotocin-induced diabetic rats FASEB J. 2012; 26:1128.3	2012
Hamza SM, Dubinion JH, Adi A, Hall JE. Melanocortin 4 receptors in the paraventricular nucleus of the hypothalamus do not mediate the chronic metabolic or cardiovascular effects of leptin after established obesity in mice FASEB J. 2012; 26:876.13	2012
do Carmo JM, da Silva AA, Hall JE. Metabolic and appetite responses to fasting and refeeding in mice with Shp2 deletion in forebrain neurons FASEB J. 2012; 26:877.2	2012
Bassi M, do Carmo JM, Colombari R, Hall JE. Leptin treatment within RVLM/RTN regions enhances ventilatory response to CO2 in ob/ob mice Neuroscience. 2011; 62.A820.11	2011
do Carmo JM, da Silva AA, Hall JE. Differential control of appetite and cardiovascular function after selective rescue of melanocortin-4 receptor in proopiomelanocortin neurons Hypertension. 2011; 58:e9	2011
Bassi M, Nakamura N, Colombari D, Menani JV, Glass ML, Hall J, Colombari E. Effects of central injections of leptin or melanocortin antagonist on arterial pressure and ventilatory responses to hypercapnia Hypertension. 2011; 58:e136	2011
Dubinion J, do Carmo J, Munusamy S, Hamza S, da Silva A, Hall JE. STAT3 inactivation in POMC neurons attenuates leptin-induced elevations in arterial pressure Hypertension. 2011; 58:e36	2011
Hamza SM, Hildebrandt DA, Hall JE. Acute mineralocorticoid receptor blockade produces rapid renal vasodilation with no impairment of autoregulation in vivo FASEB J. 2011; 25:lb646	2011
do Carmo JM, da Silva AA, Rushing JS, Hall JE Cardiovascular and metabolic responses to chronic central MC3/4R antagonism in obese Zucker rats FASEB J. 2011; 25:823.6	2011
do Carmo JM, Bassi M, Hamza SM, da Sila AA, Hall JE. Cardiovascular and metabolic responses to thermoneutrality and cold ambient temperature in lean and obese leptin deficient mice FASEB J. 2011; 25:1028.4	2011
Dwyer TM, Stec DE, Hall JE, Csongradi E. Hyaluronan is required for the renal medulla to maximally concentrate urine FASEB J. 2011; 25:1079.5	2011
Fu Y, Hall JE, Lin L, Gomez-Sanchez C, Liu R. Aldosterone blunts tubuloglomerular feedback by activating mineralocorticoid receptors on the macula densa Hypertension. 2010; 56:e158	2010
da Silva AA, Dubinion JH, do Carmo JM, Hall JE. Chronic central nervous system MC3/4R blockade attenuates the hypertension induced by peripheral nitric oxide synthase blockade but not by angiotensin II infusion Hypertension. 2010; 56:e103	2010
do Carmo JM, Silva AA, Hall JE. Divergeny chronic metabolic and cardiovascular responses to leptin: effects of ambient temperature Hypertension. 2010; 56:e105	2010
Munusamy S, do Carmo JM, Hosler JP, Hall JE. Role of mitochondrial dysfunction and ER stress in the development of obesity-induced renal injury Hypertension. 2010; 56:e62	2010
Smith GH, Hall ME, Stec DE, Hall JE. Cardiac-specific Cre-recombinase causes a dose-dependent transient reduction in systolic function FASEB J. 2010; 24:596.3	2010
Freeman JN, do Carmo JM, Hall JE, da Silva AA. Central NPY deficiency does not enhance the chronic actions of melanocortin 3 and 4 receptors (MC3/4R) activation on glucose homeostasis, appetite and cardiovascular function in diabetic mice FASEB J. 2010; 24:597.6	2010
do Carmo JM, Bassi M, da Silva AA, Hall JE. Chronic central nervous system MC3/4R activation exacerbates the cardiovascular responses to peripheral nitric oxide synthase inhibition FASEB J. 2010; 24:1051.1	2010
Bassi M, do Carmo JM, Silva AA, Hall JE. Chronic CNS actions of adiponectin on appetite, metabolism and blood pressure FASEB J. 2010; 24: 780.1	2010
do Carmo JM, Silva AA, Morgan J, Hall JE. Inhibition of soluble epoxide hydrolase reduces food intake and increases metabolic rate in mice fed high fat-high fructose diet FASEB J. 2010; 24: 996.2	2010
Bassi M, do Carmo JM, Hamza S, Hall JE. Leptin deficiency impairs hypercapnic ventilatory responses independently of changes in body weight FASEB J. 2010; 24: 1026.4	2010
Freeman JN, doCarmo JM, Hall JE, daSilva AA. Central neuropeptide Y (NPY) deficiency does not enhance the dietary or cardiovascular responses to chronic activation of melanocortin 3 and 4 receptors (MC3/4R) Hypertension. 2009; 54:e103	2009
doCarmo JM, Bassi M, daSilva AA, Hall JE. Control of cardiovascular, metabolic and respiratory functions during prolonged obesity in leptin-deficient and diet-induced obese mice Hypertension. 2009; 54:e104	2009
doCarmo JM, daSilva AA, Hall JE. Divergent control of appetite, cardiovascular and metabolic functions by leptin in mice with leptin receptor deletion in POMC neurons Hypertension 2009; 54:e102	2009
do Carmo JM, da Silva AA, Hall JE. Cardiovascular and metabolic regulation in mice with Shp2 deletion in forebrain neurons FASEB J. 2009; 23:785.5	2009
Dubinion JH, da Silva AA, do Carmo JM, Hall JE. Cardiovascular and metabolic responses to chronic central infusion of leptin in rats fed a high fat diet FASEB J. 2009; 23:1015.5	2009
Dubinion JH, da Silva AA, do Carmo JM, Hall JE. Cardiovascular and metabolic responses to chronic cPYY infusion FASEB J. 2009; 23:983.4	2009
do Carmo JM, Hall JE, da Silva AA. Chronic central leptin infusion restores sympatho-vagal balance, cardiovascular variability, and baroreflex sensitivity in diabetic rats Am J Physiol: Heart Circ Physiol. 2008; 295:H1974-H1981	2008
do Carmo JM, da Silva AA, Hall JE. Impaired baroreflex sensitivity and absence of hypertension in old leptin deficient obese mice Hypertension. 2008; 52:e104.P244	2008
Hall JE. Obesity, hypertension and renal hemodynamics Proceedings of the International Society of Hypertension Nexus Symposium, Dublin, Ireland, 2008	2008
Dubinion J, Silva A, Dreher A, Hall JE. Cardiovascular and metabolic responses to chronic central MC3/4R antagonism in rats fed a high fat diet FASEB J. 2008; 22:947.4	2008
do Carmo JM, da Silva AA, Brandon E, Hall JE. Cardiovascular function and metabolism in old melanocortin-4 receptor deficient obese mouse FASEB J. 2008; 22:947.2	2008
da Silva AA, do Carmo JM, Freeman JN, Hall JE. Chronic MC3/4R activation does not mimic the actions of leptin on baroreceptor sensitivity and heart rate regulation in diabetic rats FASEB J. 2008; 22:947.5	2008
Hall ME, Hall JE, Smith G, Stec D. Rapid cardiac dysfunction caused by inducible cardiac specific leptin receptor deletion FASEB J. 2008; 22:743.3	2008
Brandon E, do Carmo JM, da Silva AA, Hosler JP, Hall JE. Renal lipid accumulation and mitochondrial function in leptin deficient and melanocortin-4 deficient obese mice FASEB J. 2008; 22:947.3	2008
Lee JH, Liu J, Taylor HA, Hall JE, Dubbert P, Crook E, Garrison R. Insulin Resistance and Obesity in Relation to Cardiovascular Disease Risk Factors in Non-Diabetic Overweight/Obese Participants of Jackson Heart Study Circulation 2008	2008
do Carmo JM, da Silva AA, Hall JE. Protection against obesity and hypertension induced renal injury in melanocortin 4-deficient mice treated with L-NAME Proceedings of Jackson Cardiovascular-Renal Meeting, Jackson, MS, USA, 2008	2008
Hall JE. Renal-pressure natriuresis - An infinite gain feedback mechanism for long-term blood pressure regulation? Proceedings of International Society of Nephrology Nexus Symposium, Vienna, Austria, 2007	2007
da Silva AA, Brandon E, do Carmo JM, Hall JE. Endogenous activity of the CNS melanocortin system contributes to the elevated arterial pressure in spontaneously hypertensive rats Proceedings of the Inter-American Society of Hypertension, Miami, FL, May 2007	2007
Ying Z, Ryan MJ, Webb RC, Hall JE. Inhibitor kappaB kinase 2 (IKK2) is necessary for vasoconstriction FASEB J. 2007; 21:lb539	2007
Brandon EL, Cantwell L, Gu JW, Hall JE. Obesity enhances melanoma tumor growth independently of circulating leptin FASEB J. 2007; 21:763.3	2007
daSilva AA, Tallam LS, Liu J, Brandon E, Hall JE. A functional melanocortin system is required for the CNS actions of leptin on peripheral glucose regulation and cardiovascular function FASEB J. 2006; 20:A1168	2006
Tallam LS, Roberts JV, daSilva AA, Hall JE. Impact of obesity on renal structure and function in the absence of hypertension: Eidence from the melanocortin-4 receptor (MC4R) deficient mice FASEB J. 2006; 20:A1168	2006
daSilva AA, Tallam LS, Liu J, Hall JE. CNS actions of leptin play a major role in peripheral glucose regulation independent of adrenergic activation Hypertension. 2005; 46:823	2005
daSilva AA, Kuo JJ, Tallam LS, Liu J, Hall JE. Role of the central melanocortin system in regulating arterial pressure in SHR Hypertension. 2005; 46:867	2005
Tallam LS, daSilva AA, Hall JE. Role of the melanocortin-4 receptor in mediating the chronic cardiovascular and metabolic actions of leptin Hypertension. 2005; 46:822	2005
daSilva AA, Kuo JJ, Tallam LS, Brown P, Liu J, Hall JE. Chronic cardiovascular, metabolic and renal actions of central hyperleptinemia in type-1 diabetic rats FASEB J. 2005; 19:A631	2005
Tallam LS, Stec DE, daSilva AA, Hall JE. Renal changes in melanocortin-4 receptor (MC4R(-/-)) deficient mice that are severly obese but not hypertensive FASEB J. 2005; 19:A1581	2005
Liu J, da Silva AA, Meng S, Hall JE. Chronic central hyperinsulinemia transiently decreases food intake without changing arterial pressure or heart rate in rats Hypertension. 2004; 44:560	2004
Gu JW, Gadonski G, Granger JP, Kodali M, Fortepiani L, Hall JE. Exercise training reduces blood pressure in LDLR gene knockout (-/-) mice Hypertension. 2004; 44:507	2004
Tallam LS, Stec DE, da Silva AA, Kuo JJ, Hall JE. Melanocortin-4 receptor deficient mice are neither hypertensive nor salt-sensitive despite obesity, insulin resistance and hyperleptinemia Hypertension. 2004; 44:503	2004
Meng S, da Silva AA, Liu J, Tallam LS, Hall JE. Role of oxidative stress in mediating chronic cardiovascular actions of leptin Hypertension. 2004; 44:504	2004
da Silva AA, Kuo JJ, Tallam LS, Hall JE. Chronic cardiovascular and dietary responses to activation of melanocortin 3/4 receptors in a model of diet-induced obesity J Hypertens. 2004; 22 (suppl I):s202	2004
da Silva AA, Kuo JJ, Tallam LS, Hall JE. Blood pressure regulation in rats whose mothers were fed a low protein diet during gestation; role of endothelin-1 FASEB J. 2004; 18:A738	2004
Kuo JJ, Silva AA, Tallam LS, Hall JE. Chronic cardiovascular and renal actions of melanin concentrating hormone FASEB J. 2004; 18:A297	2004
Liu J, Hall JE. Mechanical stretch and oleic acid interact to syimulate TGF-1 and collagen I formation in glomerular mesangial cells and this response is blocked by PPAR activation FASEB J. 2004; 18:A303	2004
Tallam LS, Kuo JJ, Silva AA, Hall JE. Role of agouti related peptide in chronic regulation of cardiovascular and renal function FASEB J. 2004; 18:A294	2004
Kuo JJ, da Silva AA, Tallam LS, Hall JE. Role of adrenergic activity in cardiovascular and renal responses to chronic hypothalamic melanocortin receptor activation Hypertension. 2003; 42:422	2003
da Silva AA, Kuo JJ, Tallam LS, Hall JE. The role of endothelin-1 in blood pressure regulation in a rat model of diet-induced visceral obesity and hypertension Hypertension. 2003; 42:394	2003
Hildebrandt D, Henegar J, Hall JE. Chronic increases in intrarenal angiotensin II do not cause renal injury independent of hypertension Proc Inter-American Soc Hyper. 2003, p.73	2003
Silva AA, Kuo JJ, Hall JE. Hypothalamic melanocortin-3/4 receptor inhibition abolishes the dietary and cardiovascular responses to chronic leptin infusion Proc Inter-American Soc Hyper. 2003, p.89	2003
De Paula RB, da Silva AA, Hall JE. Role of aldosterone in obesity-induced hypertension Proc Inter-American Soc Hyper. 2003; 50	2003
Gu, JW, Fortepiani L, Reckelhoff JF, Adair TA, Wang J, Hall JE. Increased expression of vascular endothelial growth factor (VEGF) and capillary density in heart of spontaneously hypertensive rats FASEB J. 2003; 17:A845	2003
Liu J, Kuo J, Dai Y, Klett C, Hall JE. Mechanical stretch enhances angiotensin II stimulated TGF-b1, collagen IV production, and upregulation of AT1 receptor in mesangial cells FASEB J. 2003; 17:A488	2003
Hall JE, Kuo J, da Silva A, Tallam L, Liu J, Dai Y. Obesity hypertension, sympathetic activation and neuroendocrine pathways Clin Auton Res. 2003; 13:112	2003
Kuo JJ, Silva AA, Hall JE. Chronic cardiovascular and renal responses to melanocortin-4 receptor activation or inhibition Hypertension. 2002; 40:386	2002
Kuo JJ, Silva A, Hall JE. Cardiovascular and renal responses to chronic hypothalamic melanocortin-4 blockade FASEB J. 2002; 16:A793	2002
Gu JW, Wang J, Stockton A, Adair TH, Henegar L, Hall JE. Comparison of gene expression profiles in kidney cortex and medulla of obese and lean dogs FASEB J. 2002; 16:A820	2002
Liu J Kuo J, Tang J, Henegar L, Hall JE. Increases expression of heat shock protein 47, mitogen-sctivated kinase-1, and collagen IV in mesangial cells after sustained mechanical stretch FASEB J. 2002; 16:A92	2002
Liu J Kuo J, Tang J, Henegar L, Hall JE. Sustained mechanical stretch upregulates expression of TGF-β and TGF-β type I receptors in glomerular mesangial cells FASEB J. 2002; 16:A93	2002
Klett CP, Kelley KL, Sirous ZN, Henegar L, Hall JE. Gene expression profiling in renal cortex and inner medulla of lean and obese dogs Hypertension. 2001; 38:478	2001
Carlyle ME, Jones OB, Kuo JJ, Hall JE. Role of adrenergic activity in mediating chronic cardiovascular actions of leptin Hypertension. 2001; 38:506	2001
Fitzgerald SF, Henegar JR, Brands MW, Henegar LK, Hall JE. Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats J Hypertens. 2001; 19:s95	2001
Kuo JJ, Jones OB, Hall JE. Chronic cardiovascular and renal actions of leptin during hyperinsulinemia FASEB J. 2001; 15:A466	2001
Gu JW, Wang J, Lokitz B, Al-Turk A, Adair TH, Henegar L, Hall JE. Expression profile arrays of 375 genes in kidney medulla of obese and lean dogs FASEB. J. 2001; 15:A787	2001
Hussain T, Lokhandwala MF, Henegar J, Henegar L, Hall JE. Increased expression of Na, H-exchanger and Na,K-ATPase in renal cortex of obese dogs fed a high fat diet FASEB. J. 2001; 15:A134	2001
Henegar JR, Hall JE. Ultrastructural changes in the glomerulus in the early stages of obesity FASEB J. 2001; 15:A834	2001
Hall JE. Renal mechanisms of obesity hypertension Kidney Blood Press Res. 2000; 23:51	1999
Khalil RA, Crews JK, Carroll JF, Hall JE. Enhancement of Ca++ entry mechanisms of arterial vasoconstriction with low salt diet. Effect of obesity Hypertension. 1999; 33:1081	1999
Young A, Kolterman O, Hall JE. Amylin- innocent in essential hypertension? Diabetologia. 1999; 42:1029	1999
Hall JE. Basic science review of salt intake and cardiovascular disease Am J Hypertension. 1999; 12:231A	1999
Hall JE. Obesity, hypertension and end-stage renal disease Proc XIII Scientific Meeting Inter-American Soc. Hypertension. 1999; 96A	1999
Shek EW, Kim PK, Hall JE. Adrenergic blockade prevents leptin-induced hypertension Fed Proc. 1999; 13:A456	1999
Fitzgerald SM, Hall JE, Brands MW. Rapid hypotensive response to fasting in spontaneously hypertensive rats (SHR) Fed Proc 1999; 13:A457	1999
Hildebrandt DA, Kirk D, Hall JE. Renal and cardiovascular responses to chronic increases in cerebrovascular free fatty acids Fed Proc. 1999; 13:A780	1999
Henegar JR, Hall JE. Role of endothelin in blood pressure control in lean and obese dogs Fed Proc. 1999; 13:A781	1999
Hall JE, Jones DW, Fletcher BW, Cameron J, Mehrotra BD, Mehrotra B, Kirchner KA. Jackson Heart Study symposium on cardiovascular disease in African-Americans Am J Med Sci. 1999; 317:141	1999
Shek EW, Keen HL, Brands MW, Hall JE. Blockade of nitric oxide synthesis amplifies insulin-induced hypertension in rats Hypertension. 1998; 32:592	1998
Tyagi SC, Mujumdar VS, Shek EW, Brands MW, Hayden MR, Hall JE. Hyperhomocyst(e)inemia induces cardiovascular hypertrophy, fibrosis and hypertension Hypertension. 1998; 32:629	1998
Wofford MR, Adair C, Anderson DC, Hall JE, Miller MM, Jones DW. α and β adrenergic blockade in obese and lean hypertensive subjects Hypertension. 1998; 32:595	1998
Brands MW, Keen HL, Hailman AE, Hall JE. Chronic intravenous glucose infusion raises blood pressure in rats FASEB J. 1998; 12:A94	1998
Shek EW, Hall JE, Mujumdar VS, Tyagi SC. Hyperhomocysteinemia alters renal hemodynamics and cardiovascular function FASEB J. 1998; 12:A42	1998
Tyagi SC, Mujumdar VS, Smiley LM, Coleman TG, Hall JE. Hyperhomocysteinemia causes endothelial injury and vascular dysfunction FASEB J. 1998; 12:A328	1998
Hall JE, Henegar JR, Shek EW, Brands MW. Role of renin-angiotensin system in obesity hypertension Circulation. 1997; 96:I-33	1997
Shek EW, Brands MW, Hall JE. Cardiovascular and renal actions of chronic central nervous system leptin infusion Hypertension. 1997; 30:472	1997
Henegar JR, Shek EW, Henegar L, Hall JE. Renal functional and structural changes in the early stages of obesity Hypertension. 1997; 30:474	1997
Hall JE. Cardiovascular and renal pathophysiology of obesity Am J Hypertens. 1997; 10:234A	1997
Shek EW, Keen HL, Henegar JR, Brands MW, Hall JE. Does increased leptin contribute to obesity hypertension? FASEB J. 1997; 11:A258	1997
Keen HL, Brands MW, Shek EW, Hall JE. Maintenance of baseline angiotensin II potentiates insulin-hypertension FASEB J. 1997; 11:A258	1997
Hall JE. Renal mechanisms of obesity hypertension and relevance to essential hypertension Proc. XXXIII Internat. Cong. Physiol. Sci., L058.02, 1997	1997
Hall JE, Van Vliet BN, Garrity CA, Brands MW. Obesity hypertension- Role of adrenergic mechanisms Hypertension. 1996; 21:528	1996
Keen Hl, Brands MW, Shek EW, Hall JE. Thromboxane synthesis is required for full expression of angiotensin-hypertensin Hypertension. 1996; 28:537	1996
Zappe DH, Capel WT, Keen HL, Shek EW, Brands MW, Hall JE. Role of renal afferent nerves in obesity-induced hypertension Am J Hypertens. 1996; 9:20A	1996
Coleman F, Alonso-Galicia M, Summers RL, Coleman TG, Hall JE. A computer simulation of the role of renal medullary compression in obesity hypertension FASEB J. 1996; 10:A397	1996
Shek EW, Keen HL, Brands MW, Hall JE. Inhibition of nitric oxide synthesis enhances insulin-hypertension in conscious rats FASEB J. 1996; 10:A556	1996
Keen HL, Brands MW, Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin-hypertension in rats FASEB J. 1996; 10:A556	1996
Summers RL, Woodward LH, Sanders DY, Hall JE. Using graphical analysis for the study of metabolic states FASEB J. 1996; 10:A264	1996
Keen HL, Brands MW, Alonso-Galicia M, Hall JE. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension Hypertension. 1995; 26:552	1995
Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats is dependent on angiotensin II Hypertension. 1995; 26:554	1995
Brands MW, Gardner AL, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Chronic ACE inhibition prevents insulin-hypertension in Sprague-Dawley rats Am J Hypertens. 1995; 8:55A	1995
McKay MK, Hall JE, Hester RL. Alterations in arteriolar diameter by insulin in the cremaster muscle FASEB J. 1995; 9:A20	1995
Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin-hypertension in Sprague-Dawley rats FASEB J. 1995; 9:A297	1995
Zappe DH, Kassab SE, Brands MW, Hall JE. Chronic adrenergic blockade attenuates the development of hypertension due to weight gain in dogs FASEB J. 1995; 9:A296	1995
Alonso-Galicia M, Brands MW, Smith MJ, Zappe DH, Hall JE. Chronic AT1 receptor blockade in obese Zucker rats FASEB J. 1995; 9:A296	1995
Hall JE. Insulin resistance and hypertension in the elderly Proceedings from the Internatonal Congress of Hypertension in the Elderly. 1995. p 53	1995
Hall JE. Mechanisms of obesity-associated hypertension and relevance to essential hypertension Proceedings from the XIII International Congress of Nephrology. 1995. p 32	1995
Kassab SE, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Bilateral renal denervation prevents the development of obesity-induced hypertension in dogs Hypertension. 1994; 3:375	1994
Alonso-Galicia M, Dwyer TM, Hererra GA, Hall JE. Increased hyaluronic acid in the inner medulla of obese dogs Hypertension. 1994; 3:402	1994
Hall JE, Garrity CA, Zappe DH, Brands MW. Long-term systemic hemodynamic actions of insulin: Role of nitric oxide and B-adrenergic mechanisms Hypertension. 1994; 3:375	1994
Hall JE. Neurohumoral and renal mechanisms of obesity hypertension Am J Hypertens. 1994; 7:26A	1994
Kassab S, Wilkins C, Kato T, Mizelle L, Hall J, Granger J. Renal nerves play an important role in mediating the sodium retention in response to a high fad diet in conscious dogs Am J Hypertens. 1994; 7:26A	1994
Alonso-Galicia M, Dwyer TM, Herrera G, Hall JE. Altered renal medullary glycosaminoglycan (GAG) content in obese dogs FASEB J. 1994; 8:A580	1994
Zappe DH, Garrity CA, Brands MW, Hall JE. Role of B-adrenergic systems in mediating chronic systemic hemodynamic effects of insulin FASEB J. 1994; 8:A527	1994
Kassab S, Wilkins C, Kato T, Mizelle L, Hall J, Granger JP. Role of renal nerves in mediating the sodium retention in obese dogs FASEB J. 1994; 8:A527	1994
Brands MW, Harrison DA, Hall JE. Sustained intrarenal calcium infusion does not lower arterial pressure in normal dogs FASEB J. 1994; 8:A527	1994
Hildebrandt DA, Heath BJ, Hall JE. Systemic arterial pressure and heart rate responses to acute and chronic carotid or vertebral artery insulin infusion FASEB J. 1994; 8:A528	1994
Mitchell CL, Garrity CA, Zappe D, Brands MW, Hall JE. Adrenergic mechanisms contribute to obesity-induced hypertension MS Acad Sci. 1994; 39:55	1994
Torrey C, Van Vliet BN, Garrity CA, Hall JE. Cholinergic control of heart rate in obesity MS Acad Sci. 1994; 39:54	1994
Garrity CA, Brands MW, Hall JE. Chronic blockade of endothelial-derived nitric oxide (EDNO) in obese and normal dogs MS Acad Sci. 1994; 39:55	1994
Holman MG, Brands MW, Garrity CA, Hall JE. Chronic hyperinsulinemia has an exaggerated pressor and chronotropic effect in SHR compared to WKY rats MS Acad Sci. 1994; 39:54	1994
Alonso-Galicia M, Dwyer TM, Hall JE. Estimation of renal medullary glycosaminoglycan (GAG) content in obese dogs MS Acad Sci. 1994; 39:53	1994
Arnold MD, Brissie R, Soonz JS, Dwyer T, Hall J, Herrera GA. Obesity associated renal medullary changes Lab Investigations. 1994; 70:156A	1994
Hall JE, Garrity CA, Brands MW. Renal and systemic hemodynamics during chronic endothelial derived nitric oxide (EDNO) blockade in obesity hypertension Proceedings from the 15th Meeting of the International Society of Hypertension. 1994	1994
Hall JE. Resistance to metabolic actions of insulin: A cause or a consequence of hypertension Proceedings from the 76th Meeting of the Endocrine Society. 1994; 190	1994
Keen HL, Brands MW, Harrison DL, Hall JE. Sympathetic blockade prevents the chronotropic but not the pressor response to chronic insulin infusion in rats MS Acad Sci. 1994; 39:54	1994
Brands MW, Garrity CA, Hall JE. High-fructose diet does not cause hypertension in rats Am J Hypertens. 1993; 6:59A	1993
Hall JE, Van Vliet BN, Garrity CA, Brands MW. Adrenergic mechanisms and obesity-induced hypertension FASEB J. 1993; 7:A188	1993
Van Vliet BN, Torrey C, Hall JE. Autonomic determinants of resting heart rate in obese dogs FASEB J. 1993; 7:A624	1993
Brands MW, Garrity C, Holman MG, Hall JE. Exaggerated pressor response to chronic hyperinsulinemia in SHR versus WKY rats FASEB J. 1993; 7:A6	1993
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Systemic hemodynamic actions of long-term intravertebral angiotensin II infusion FASEB J. 1993; 7:A405	1993
Hall JE, Connell RD, Garrity CA, Brands MW. Endothelial-derived relaxing factor (EDRF) in long-term circulatory control in normal and obese dogs Circulation. 1992; 86:I489	1992
Hall JE, Van Vliet BN, Garrity CA, Connell RD, Brands MW. Role of increased adrenegic activity in obesity-induced hypertension Circulation. 1992; 86:I541	1992
Hall JE. The kidney, obesity, and essential hypertension Hypertension. 1992; 19 (Suppl. 1): I-1	1992
Gahnem FJ, Hall JE, Sealey JE. High fat diet increases plasma prorenin in normal dogs Am J Hypertens. 1992; 5:54A	1992
Hildebrandt DA, Van Vliet BN, Brands MW, Mizelle HL, Hall JE. Chronic intravertebral (IVT) angiotensin II infusion increases arterial pressure FASEB J. 1992; 6:A1469	1992
Dzielak DJ, Doherty MC, Callahan J, Hall JE. Partial renal infarct hypertension does not develop in animals treated with DUP-753 FASEB J. 1992; 6:A945	1992
Brands MW, Alonso-Galicia M, Mizelle HL, Hildebrandt DA, Hall JE. Renal perfusion pressure and sodium balance in DOCA-salt sensitive hypertension FASEB J. 1992; 6:A1469	1992
Summers RL, Montani JP, Hall JE. Theoretical analysis of the mechanisms of steady-state insulin resistance FASEB J. 1992; 6:A1492	1992
Hall JE, Brands MW, Dixon WN, Mizelle HL, Hildebrandt DA. Blood pressure regulation during chronic hyperinsulinemia in obese, insulin resistant dogs Proceedings from the XIV Meeting of the International Society of Hypertension. 1992, p 224	1992
Hall JE, Herrera GA, Granger JP. Renal pathophysiology in obesity-induced hypertension Hypertension. 1991; 18:395	1991
Brands MW, Hall JE, Hildebrandt DA, Mizelle HL. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive Am J Hypertens. 1991; 4:13A	1991
Hall JE, Brands MW, Dixon WN, Mizelle HL, Hildebrandt DA. Renal function in obesity-associated hypertension in conscious dogs Am J Hypertens. 1991; 4:118A	1991
Brands MW, Hall JE, Mizelle HL, Hildebrandt DA. Chronic angiotensin converting enzyme inhibition (ACEI) improves cardiac output and fluid balance during heart failure FASEB J. 1991; 5:A738	1991
Hall JE, Brands MW, Dixon WN, Mizelle HL, Hildebrandt DA. Hyperinsulinemia does not elevate blood pressure in obese hypertensive dogs FASEB J. 1991; 5:A737	1991
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Low salt diet abolishes the renal response to urodilation FASEB J. 1991; 5:A1019	1991
Mizelle HL, Montani JP, Hester RL, Hall JE. Renal hemodynamics and sodium excretion during chronic reductions in renal perfusion pressure FASEB J. 1991; 5:A737	1991
Miller BA, Dixon WN, Brands MW, Mizelle HL, Hildebrandt DA, Hall JE. Control of arterial pressure and renal function during hyperinsulinemia in obese dogs MS Acad Sci. 1991; 36:46	1991
Dixon WN, Brands MW, Miller BA, Mizelle HL, Hildebrandt DA, Hall JE. Renal and systemic hemodynamics in obesity-associated hypertension MS Acad Sci. 1991; 36:46	1991
Mizelle HL, Montani JP, Hester RL, Hall JE. Role of renal perfusion pressure in long-term control of sodium excretion Hypertension. 1990; 16:327	1990
Mizelle HL, Gaillard CA, Manning RD, Hall JE. ANP decreases cardiac output independent of blood volume changes in conscious nephrectomized dogs Am J Hypertens. 1990; 3:82A	1990
Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Chronic intrarenal hyperinsulinemia and blood pressure regulation Am J Hypertens. 1990; 3:26A	1990
Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. The hemodynamic response to chronic hyperinsulinemia Am J Hypertens. 1990; 3:19A	1990
Mizelle HL, Brands MW, Gaillard CA, Manning RD, Dixon WN, Hildebrandt DA, Hall JE. Chronic hemodynamic actions of the atrial natriuretic peptide (ANP) FASEB J. 1990; 4:A694	1990
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Comparison of the renal action of urodilation (URD) and atrial natriuretic peptide (ANP) FASEB J. 1990; 4:A695	1990
Brands MW, Hall JE, Hildebrandt DA, Mizelle HL. Hypertension during chronic hyperinsulinemia in conscious rats FASEB J. 1990; 4:A817	1990
Hall JE, Mizelle HL, Brands MW, Hildebrandt DA. Salt-induced hypertension: Role of pressure natriuresis FASEB J. 1990; 4:A817	1990
Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Control of arterial pressure during chronic intrarenal or systemic hyperinsulinemia J Hypertens. 1990; 8 (Suppl. 3): 59	1990
Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. Hemodynamic responses to chronic hyperinsulinemia Proceedings from the XI International Society of Hypertension. 1990; p 160	1990
Hall JE, Dixon WN, Brands MW, Mizelle HL, Hildebrandt DA. Obesity, hyperinsulinemia, and hypertension: Control of renal function and systemic hemodynamics J Am Soc Nephrol. 1990; 1:490	1990
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Renal pressure natriuresis and urodilation: A new natriuretic hormone J Am Soc Nephrol. 1990; 1:417	1990
Hall JE. Renal vasodilation: Pathophysiological and therapeutic implications Eur J Pharmacol. 1990; 183:45	1990
Mizelle HL, Brands MW, Hildebrandt DA, Hall JE. Role of renal perfusion pressure in chronic hypercalcuria J Am Soc Nephrol. 1990; 1:496	1990
Gaillard CA, Hall JE, Mizelle HL, Hildebrandt DA, Montani JP. Atrial natriuretic factor and long-term blood pressure control: Interaction with renin-angiotensin-aldosterone system Kidney Int. 1990; 37:339	1990
Hall JE. What is the role of the intrarenal renin-angiotensin system in blood pressure control? Pediatr Nephrol. 1990; 4:87	1990
Gaillard CA, Hall JE, Mizelle HL, Hildebrandt DA, Montani JP. Chronic low dose ANF infusion causes hypotension in sodium depleted dogs Am J Hypertens. 1989; 2:33A	1989
Hall JE, Brands MW, Kivlighn SD, Hildebrandt DA, Mizelle HL, Gaillard CA. Hyperinsulinemia, catecholamines, and long-term blood pressure regulation Am J Hypertens. 1989; 2:32A	1989
Mizelle HL, Hall JE, Hildebrandt DA, Montani JP. Renal hemodynamics and electrolyte excretion during chronic intrarenal infusion of atrial natriuretic peptide (ANP) FASEB J. 1989; 3:A697	1989
Hall JE. Angiotensin II and renal pressure natriuresis mechanism in long-term control of arterial pressure Proceedings of the XXXI International Congress of Physiological Sciences. 1989; p 26	1989
Smith CD, Mizelle HL, Hildebrandt DA, Hall JE. Angiotensin-adenosine interactions in the renal vasculature: Mechanisms of calcium activation Kidney Int. 1989; 35:474	1989
Hall JE, Coleman TG, Mizelle HL. Arterial pressure and renal function during chronic hyperinsulinemia Kidney Int. 1989; 35:326	1989
Mizelle HL, Hall JE, Hildebrandt DA, Hall JE. Does atrial natriuretic peptide (ANP) cause chronic natriuresis? Kidney Int. 1989; 35:295	1989
Hall JE, Mizelle HL. Arterial pressure and renal function during chronic renin inhibition in conscious dogs Hypertension. 1988; 12:340	1988
Hall JE, Coleman TG, Mizelle HL. Does chronic hyperinsulinemia cause hypertension? Am J Hypertens. 1988; 1:46A	1988
Mizelle HL, Hall JE, Hildebrandt DA, Smith CD. Interactions between atrial natriuretic factor, pressure natriuresis, and the renin-angiotensin system Am J Hypertens. 1988; 1:102A	1988
Hall JE, Coleman TG, Brown CA, Mizelle HL. Arterial pressure regulation during chronic hyperinsulinemia FASEB J. 1988; 2:A1279	1988
Mizelle, HL, Hall JE, Montani JP. Renal function and the renin-angiotensin system in a model of chronic compensated congestive heart failure FASEB J. 1988; 2:A1320	1988
Guyton AC, Hall JE, Coleman TG, Norman Jr. RA, Montani JP. Long-term arterial pressure regulation and hypertension - A computer and experimental study Proceedings from Symposium on Frontiers in Cardiopulmonary Mechanics. 1988; p 15	1988
Hall JE, Mizelle HL, Woods LL, Montani JP. Regulation of Na balance in norepinephrine hypertension: Role of pressure natriuresis Kidney Inter. 1988; 33:296	1988
Woods LL, Mizelle HL, Hall JE. Role of increased renal artery pressure in control of sodium excretion during ACTH hypertension Kidney Int. 1988; 33:430	1988
Woods LL, Mizelle HL, Hall JE. Role of the liver in controlling renal hemodynamics during amino acid infusion Fed Proc. 1987; 46:637	1987
Mizelle HL, Hall JE, Montani JP, Woods LL. Role of the renal nerves in the sodium retention of congestive heart failure Fed Proc. 1987; 46:1235	1987
Woods LL, Mizelle HL, Hall JE. Control of renal hemodynamics during amino acid infusion: Role of the liver Kidney Int. 1987; 31:427	1987
Hall JE. Arterial pressure and body fluid homeostasis Fed Proc. 1986; 45:2862-2863	1986
Mizelle, HL, Woods LL, Montani JP, Hall JE. Interactions between angiotensin and the renal nerves during chronic sodium restriction Fed Proc. 1986; 45:539	1986
Woods LL, Mizelle HL, Hall JE. Tubuloglomerular feedback control of renal hemodynamics during hyperglycemia Fed Proc. 1986; 45:515	1986
Woods LL, Mizelle HL, Hall JE. Mechanisms controlling renal hemodynamic responses to amino acids and glucose: Role of tubuloglomerular feedback Proceedings from the International Union of Physiological Scientists. 1986; 16:29	1986
Montani JP, Hall JE, Guyton AC. NA/K ATPase inhibition and long-term blood pressure control Proceedings from the International Union of Physiological Scientists. 1986; 16:602	1986
Hall JE, Mizelle HL, Woods LL. Renal actions of angiotensin and aldosterone Proceedings from the International Union of Physiological Scientists. 1986; 16:375	1986
Woods LL, Mizelle HL, Hall JE. Control of renal hemodynamics during hyperglycemia: Role of macula densa feedback Kidney Int. 1986; 29:389	1986
Montani JP, Hall JE, Guyton AC. Na/K pump inhibition with reduced renal mass does not produce chronic hypertension Kidney Int. 1986; 29:253	1986
Mizelle HL, Woods LL, Montani JP, Dzielak DJ, Hall JE. Role of the renal nerves in adaption to chronic sodium restriction Kidney Int. 1986; 29:253	1986
Hall JE, Montani J-P, Woods LL, Mizelle HL. Control of fluid balance in vasopressin hypertension: Role of renal perfusion pressure Fed Proc. 1985; 44:1011	1985
Woods LL, Mizelle HL, Montani JP, Richards RM, Cornell JE, Hall JE. Control of renal hemodynamics and electrolyte excretion during amino acid infusion Fed Proc. 1985; 44:1739	1985
Montani JP, Hall JE, Guyton AC. Na/K pump inhibition increases vascular reactivity but does not produce chronic hypertension Fed Proc. 1985; 44:1555	1985
Mizelle HL, Woods LL, Montani JP, Hall JE. Role of renal nerves in adaptation to chronic sodium deprivation Fed Proc. 1985; 44:1011	1985
Hall JE, Montani JP. Role of increased renal arterial pressure in escape from antidiuretic effects of vasopressin Kidney Int. 1985; 27:192	1985
Hall JE, Granger JP, Montani JP, Premen AJ. Renal hemodynamic actions of adenosine: Interactions with angiotensin and tubuloglomerular feedback Fed Proc. 1984; 43:409	1984
Premen AJ, Hall JE. Role of adenosine in autoregulation of glomerular filtration rate and renal blood flow Kidney Int. 1984; 25:291	1984
Dzielak DJ, Norman Jr RA, Hall JE. Servo-occluder technique for characterization of arterial pressure changes caused by CNS ischemia Fed Proc. 1984; 43:694	1984
Hall JE, Montani JP. Adaptation of renal excretion to chronic servo-controlled reduction in perfusion pressure: Role of GFR autoregulation and decreased tubular reabsorption Proceedings of the X International Society of Hypertension. 1984; 423	1984
Olsen ME, Hall JE, Montani JP, Guyton AC. Angiotensin II natriuresis and diuresis, role of renal artery pressure in anesthetized dogs Proceedings from the 10th International Society of Hypertension. 1984; 111	1984
Hall JE, Montani JP. GFR autoregulation during long-term reductions in renal perfusion pressure The Physiologist. 1984; 27:208	1984
Hall JE, Montani JP. Long-term renal autoregulation and adaptation to decreased renal perfusion pressure Proceedings from the IX International Congress of Nephrology. 1984; 394	1984
Guyton AC, Hall JE, Jackson TE. Renal afferent and efferent arteriolar control of arterial pressure Proceedings from the 10th International Society of Hypertension. 1984; 421	1984
Premen AJ, Hall JE, Smith MJ, Rushing P. Role of glucagon during protein-induced elevations in renal blood flow and glomerular filtration rate The Physiologist. 1984; 27:208	1984
Montani JP, Nuwayhid BS, Summers RL, Markov AK, Hall JE, Guyton AC. Role of Na/K ATPase activity in long-term blood pressure control Proceedings from IX International Congress of Nephrologists.1984; 394	1984
Olsen ME, Hall JE, Montani JP, Cornell J. Role of renal prostaglandins in selective protection of preglomerular vessels from angiotensin II vasoconstriction Proceedings from IX International Congress of Nephrology. 1984; 458	1984
Hall JE, Granger JP, Premen AJ. Mechanisms of aldosterone escape: Role of glomerular filtration and arterial pressure Kidney Int. 1984; 25:200	1984
Coleman TG, Davis JR MH, Hall JE. Rapid plasma renin activity changes during hemorrhage in the rat Fed Proc. 1983; 42:318	1983
Hall JE, Granger JP. Role of peripheral sympathetic nervous system in mediating the chronic blood pressure and renal hemodynamic effects of angiotensin II Fed Proc. 1983; 42:589	1983
Granger JP, Hall JE. Role of renin-angiotensin system and tubuloglomerular feedback in altering the renal responses to glandular kallikein Fed Proc. 1983; 42:590	1983
Hall JE, Granger JP, Premen AJ. Angiotensin II constricts preglomerular vessels in the presence of adenosine The Physiologist. 1983; 26:A127	1983
Premen AJ, Hall JE, Granger JP. Control of arterial pressure and renal hemodynamics during chronic intrarenal adenosine infusion The Physiologist. 1983; 26:A127	1983
Hall JE, Granger JP. Mechanisms of escape from chronic sodium retaining effects of angiotensin II Proceedings from the 29th Congress of the International Union of Physiogical Sciences. 1983; 318	1983
Olsen ME, Hall JE, Montani JP, Guyton AC. Natriuretic and antinatriuretic actions of angiotensin II: Role of renal artery pressure and proximal tubular reabsorption The Physiologist. 1983; 26:A127	1983
Granger JP, Hall JE. Control of renal hemodynamics, electrolyte excretion, and arterial pressure during acute and chronic intrarenal infusion of glandular kallikrein Kidney Int. 1983; 23:279	1983
Hall JE, Granger JP. Escape from the chronic sodium retaining actions of angiotensin IIL role of increased renal arterial pressure Kidney Int. 1983; 23:170	1983
Hall JE, Granger JP, Twu B. Interactions between angiotensin II and intrinsic autoregulatory mechanisms in control of renal segmental resistances Fed Proc. 1982; 41:1257	1982
Granger JP, Hall JE, Twu B. Long-term control of renal hemodynamics, electrolyte excretion and arterial pressure by circulating bradykinin in conscious dogs Fed Proc. 1982; 41:1247	1982
Granger JP, Twu B, Hall JE. Control of renal segmental resistances by angiotensin II in the absence of tubuloglomerular feedback J MS Acad Sci. 1982; 27: 31	1982
Twu B, Granger JP, Hall JE. Renin secretion into the renal circulation and lymph during increased ureteral pressure J MS Acad Sci. 1982; 27:31	1982
Hall JE, Granger JP. Role of angiotensin II in mediating renal hemodynamic effects of adenosine The Physiologist. 1982; 25:317	1982
Granger JP, Hall JE, Twu B. The role of circulating and endogenous kinins in long-term regulation of hemodynamics, electrolyte excretion, and arterial pressure in conscious dogs J MS Acad Sci. 1982; 27:32	1982
Kastner PK, Hall JE, Guyton AC. Autoregulation of glomerular filtration rate: Role of intrarenally formed angiotensin II Fed Proc. 1981; 40:516	1981
Granger JP, Hall JE. Does azotemia potentiate the chronic blood pressure and renal vasoconstrictor effects of aniotensin II? Fed Proc. 1981; 40:435	1981
Hall JE, Granger JP. Mechanisms of captopril's chronic blood pressure and renal hemodynamic effects Fed Proc. 1981; 40:435	1981
Granger JP, Hall JE. Effects of azotemia on control of arterial pressure, renal hemodynamics, and electrolyte excretion by angiotensin II J MS Acad Sci. 1981; 26:58	1981
Hall JE, Granger JP. Mechanisms of the chronic blood pressure and renal hemodynamic effects of captopril (SQ-14225) Proceedings from the Eighth International Society of Hypertension. 1981; 170	1981
Hall JE, Morse CL, Smith Jr. MJ, Young DB, Guyton AC. Regulation of renal hemodynamics, electrolyte excretion, and arterial pressure during chronic glucocorticoid excess Fed Proc. 1980; 39:963	1980
Kastner PR, Hall JE, Guyton AC. Renin secretion and renal hemodynamics responses following step increases in renal venous pressure before and after angiotensin converting enzyme inhibition Fed Proc. 1980; 39:949	1980
Hall JE, Guyton AC, Smith Jr. MJ, Coleman TG. Long-term relationships between arterial pressure, renal hemodynamics and sodium excretion: Role of renin-angiotensin system Proceedings from the Seventh International Society of Hypertension. 1980; 49	1980
Hall JE, Coleman TG, Guyton AC, Kastner PR, Salgado HC. Control of glomerular filtration rate by renin-angiotensin system: Role of circulating angiotensin II The Physiologist. 1979; 22:51	1979
Guyton AC, Lohmeier TE, Hall JE, Kastner PR, Hockel GM. Overall control of the circulation Proceedings from Australian Physiology and Pharmacology Society. 1979	1979
Coleman TG, Hall JE. Tubuloglomerular feedback does not explain autoregulation of renal blood flow and glomerular filtration rate The Physiologist. 1979; 22:21	1979
Hall JE, Guyton AC, Coleman TG, Smith MJ. Role of angiotensin and aldosterone in control of arterial pressure and renal hemodynamics during chronic converting enzyme inhibition Kidney Int. 1979; 16:793	1979
Hall JE, Guyton AC, Coleman TG, McCaa RE. Long-term control of renal hemodynamics and electrolyte excretion during converting enzyme inhibition The Physiologist. 1978; 21:49	1978
Hall JE, Guyton AC, Salgado HC, Balfe JW, McCaa RE. Role of [Des-Asp1] angiotensin III (AIII) and Angtiotensin II (AII) in controlling renal hemodynamics and electrolyte excretion Fed Proc. 1978; 37:307	1978
Guyton AC, Hall JE, Balfe JW, Lohmeier TE, Jackson TE, Norman Jr RA. Pathophysiological renal mechanisms that cause hypertension, hypotension, and uremia Proceedings from the VII International Congress of Nephrology. 1978 37:307	1978
Coleman TG, Hall JE. Perfused tissues: constant flow vs. constant pressure systems Proceedings from Annual Conference of Engineering in Medicine and Biology. 1978; 20:219	1978
Hall JE, Guyton AC, Coleman TG, McCaa RE. Long-term relationship between arterial pressure, urinary output, and renal hemodynamics after converting enzyme inhibition Kidney Int. 1978; 14:696	1978
Trippodo NC, Hall JE, Lohmeier TE, Guyton AC. Effect of intrarenal blockade of angiotensin II on sodium excretion in dehydrated dogs Fed Proc. 1977; 36:574	1977
Hall JE, Guyton AC, McCaa RE, Salgado HC. Control of renal hemodynamics and electrolyte excretion after converting enzyme inhibition The Physiologist. 1977; 20:40	1977
Hall JE, Guyton AC, McCaa RE, Salgado HC. Intrarenal role of the renin-angiotensin system Circulation. 1977; 56:246	1977
Guyton AC, Hall JE, Lohmeier TE, Fagard RH, Cowley Jr. AW. Salt retention and gfr autoregulation mediated by efferent arteriolar effects of intrarenal renin-angiotensin Proceedings from International Union of Physiological Sciences. 1977; 13:295	1977
Hall JE, Guyton AC, Salgado HC, McCaa RE. Changes in renal hemodynamics and body fluids during acute and chronic angiotensin II (AII) hypertension Kidney Int. 1977; 12:500	1977
Hall JE, Guyton AC. Single injection clearances of 125I-Iothalamate Fed Proc. 1976; 35:542	1976
Hall JE, Guyton AC. Uncoupling of renal blood flow (RBF) and glomerular filtration rate (GFR) autoregulation after renin depletion The Physiologist. 1976; 19:217	1976
Hall JE, Guyton AC, Cowley Jr. AW, McCaa RE, McCaa CS. Intrarenal role of angiotensin II (AII) Kid Int. 1976; 10:530	1976
Hall JE, Guyton AC, Jackson TE. Effects of increased plasma colloid osmotic pressure on renal hemodynamics and renin secretion The Physiologist. 1975; 18:238	1975
Lalone B, Schwinghamer J, Hall J. Autoregulation of skeletal muscle blood flow during hemorrhage The Physiologist. 1974; 17:270	1974
Hall J, Lalone B, Schwinghamer J, Adams T. Neurally and humorally mediated vascular responses to hemorrhage The Physiologist. 1973; 16:333	1973
Musson, JB, Lalone B, Hall J, Schwinghamer J. Skin and muscle vascular responses to hypothermia The Physiologist. 1973; 16:404	1973
Lalone B, Hall J, Musson J, Schwinghamer J. Vascular responses to adrenochrome in the dog forelimb Clin Res. 1973; 21:431	1973
Hall J, Lalone B, Buck M, Schwinghamer J Mechanisms of large vessel constriction and fluid mobilization during hemorrhage The Physiologist. 1972; 15:158	1972
Hall J, Lalone B, Buck M, Schwinghamer J Role of circulating constrictor agents in vascular response to hemorrhage Clin Res. 1972; 20:719	1972
Book Chapter
Hall ME, Wang Z, do Carmo J, Kamimura D and Hall JE Obesity and metabolic syndrome hypertension In: Disorders of Blood Pressure Regulation: Phenotypes, Mechanisms, Therapeutic Options. Eds. AE Berbari, G Mancia. Springer Publishing. 2018; 705-722.	2018
Hall JE, Granger JP, Jones DW, Hall ME Pathophysiology of hypertension. In: Hurst’s The Heart 14th ed., Eds. V. Fuster, R.Harrington, J Narula, Z. Eapen. McGraw-Hill Medical, New York. 2017; pp. 720-750	2017
Hall ME and Hall JE Pathogenesis of Hypertension In: Hypertension: A Companion to Braunwald’s Heart Disease, 3rd edition, Eds. GL Bakris, M Sorrentino. Elsevier, Inc, Philadelphia. 2017; pp. 33-51	2017
Maric C, Hall JE. Obesity, metabolic syndrome and diabetic nephropathy. In: Diabetes and the kidney, contibutions to nephrology Eds. KN Lai, SCW Tang. Karger, Basel, 2011. pp. 28-35	2011
Hall JE, Granger JP, Jones DW, Hall ME. Pathophysiology of hypertension. In: Hurst’s the heart, 13th ed Eds. V Fuster, RA O’Rourke, RA Walsh, PA Poole-Wilson. McGraw-Hill Medical, New York, 2011. pp 1549-1584	2011
Hall ME, Hall JE, Granger JP, Jones DW. Systemic hypertension: pathogenesis and etiology In: Hurst’s The Heart Manual of Cardiology, 12th ed. Eds. R.A. O’Rourke, R.A. Walsh, V. Fuster. McGraw-Hill Medical, New York, pp 339-350, 2009	2009
Hester RL, Hall JE. Local autoregulation of blood flow In: Hypertension Primer, 4th edition, American Heart Assoc. Eds. J. L. Izzo Jr. and H. C. Black. pp. 129-132, 2008	2008
Hall JE, Granger JP, Hall ME, Jones DW. Pathophysiology of hypertension In: Hurst’s The Heart, 12th ed. Eds. V. Fuster, R.A. O’Rourke, R.A. Walsh, P.A. Poole-Wilson. McGraw-Hill Medical, New York, pp. 1570-1608, 2008	2008
Coleman TG, Hall JE. Systemic hemodynamics and regional blood flow regulation In: Hypertension Primer, 4th edition, American Heart Assoc . Eds. J. L. Izzo Jr. and H. C. Black. pp. 132-135, 2008	2008
Hall JE, daSilva AA, Brandon E, Stec DE, Ying Z, Jones DW. Pathophysiology of obesity hypertension and target organ injury In: Comprehensive Hypertension. Eds. Lip, G.Y.P. and J.E. Hall. Elsevier, New York, pp. 447-468, 2007	2007
Granger JP, Hall JE. Role of the kidney sodium and fluid excretion in hypertension In: Comprehensive Hypertension. Eds. Lip, G.Y.P. and J.E. Hall. Elsevier, New York, pp. 241-263, 2007	2007
Hall JE, Jones DW, Kuo JJ, da Silva AA, Liu J, Tallam L. Obesity and hypertension: impact on cardiovascular and renal disease In: Hypertension – a Companion to Brenner and Rector’s The Kidney. Eds. S. Oparil and M. Weber. Elsevier Science, Philadelphia. pp. 464-474, 2005	2005
Hall JE, Granger JP. Regulation of fluid and electrolyte balance in hypertension- role of hormones and peptides In: Hypertension- Principles and Practice. Eds. E.J. Battegay, G.Y.H.Lip, and G.L. Bakris. Taylor and Francis Group, LLC, Boca Raton. pp 121-142, 2005	2005
Hall JE, Jones DW, Henegar J, Dwyer TM, Kuo J. Obesity hypertension, and renal disease In: Obesity: Mechanisms and Clinical Management. Ed. R.H. Eckel, Lippincott, Williams & Wilkins, Philadelphia, pp. 273-300, 2003	2003
Coleman TG, Hall JE. Systemic hemodynamics and regional blood flow regulation In: Hypertension Primer, 3rd edition, American Heart Assoc. Eds. J. L. Izzo Jr. and H. C. Black. pp. 111-114, 2003	2003
Hall JE. Historical Perspective of the Renin-Angiotensin System In: Angiotensin Protocols- Methods in Molecular Medicine. Ed. D.H. Wang. Humana Press, Inc., p. 3-22, 2000	2000
Brands MW, Hall JE. Mechanisms for chronic antihypertensive effect of angiotensin II blockade In: Angiotensin II Receptor Antagonists. Ed. M. Epstein and H. R. Brunner, Hanley & Belfus, Inc., Philadelphia, p. 171-187, 2000	2000
Hall JE, Henegar JR, Shek EW, Brands MW. The renal circulation in obesity and insulin resistance In: Advances in Organ Biology: The Renal Circulation. Ed W.P. Anderson, JAI press, Greenwich, Connecticut, p. 383-397, 2000	2000
Hall JE, Brands MW. The renin-angiotensin-aldosterone system: renal mechanisms and circulatory homeostasis In: The Kidney: Physiology and Pathophysiology, 3rd Edition. Eds. D.W. Seldin and G. Giebisch. Raven Press, New York, p. 1009-1046, 2000	2000
Hall JE, Brands MW, Jones DW, Shek EW, Henegar JR. Mechanisms of obesity hypertension and relevance to essential hypertension In: Obesity: Impact on Cardiovascular Disease. Eds. G. Fletcher, S. Grundy, and L.Hayman. Futura Publishing Co., Inc., p133-153, 1999	1999
Hall JE. Cardiovascular and Renal Pathophysiology of Obesity In: ACE Inhibitors, Diabetes, and Obesity: Molecules, Metabolism, and Management	1998
Hall JE, Brands MW, Shek EW, Henegar JR. Renal actions of angiotensin II and long-term blood pressure regulation In: Renin-Angiotensin, Ed. H. Ulfendahl and M. Aurell, Portland Press Ltd, London, p. 89-104, 1998	1998
Tyagi SC, Hayden MR, Hall JE. Role of angiotensin in angiogenesis and cardiac fibrosis in heart failure In: Angiotensin II Receptor Blockade: Physiological and Clinical Implications . Eds. N.S. Dhalla, P. Zahradka, I.M.C. Dixon, and R.E. Beamish. Progress in Experimental Cardiology 2:537-549, 1998	1998
Coleman TG, Hall JE. Systemic hemodynamics and regional blood flow regulation In: Primer on Hypertension, 2nd edition, American Heart Assoc.,Eds. J. L. Izzo Jr. and H. C. Black, p. 92-94, 1998	1998
Van Vliet BN, Hall JE, Lohmeier TE, Mizelle HL. Renal Circulation In: Nervous Control of Blood Vessels, Ed. T. Bennett and S. Gardiner. Harwood Academic Publishers, London, p. 371-433, 1996	1996
Hall JE, Guyton AC, Brands MW. Control of Sodium Excretion and Arterial Pressure by Intrarenal Mechanisms and the Renin-Angiotensin System. In: Hypertension: Pathophysiology, Diagnosis, and Management Eds. J.H. Laragh and B.M. Brenner. Raven Press, New York, 1995. p. 1451-1476	1995
Guyton AC, Hall JE, Coleman TG, Manning Jr. RD, Norman Jr. RA. The Dominant Role of the Kidneys in Long-term Arterial Pressure Regulation in Normal and Hypertensive States. In: Hypertension: Pathophysiology, Diagnosis and Management Eds. J.H. Laragh and B.M. Brenner. Raven Press, New York, 1995. p 1311-1326	1995
Hall JE, Granger JP. Role of Sodium and Fluid Excretion in Hypertension. In: Textbook of Hypertension Ed. J.D. Swales. Blackwell Scientific Pubs, Oxford, 1994. p 360-384	1994
Hall JE, Brands MW. Intrarenal Actions of Angiotensin II: Physiology and Pathophysiology. In: Current Advances in ACE Inhibtion Ed. G.A. McGregor and P. Sever. Churchill Livingstone, London, 1993. p 41-51	1993
Hall JE, Brands MW. Intrarenal and Circulating Angiotensin II and Renal Function. In: The Renin-Angiotensin System Eds. J.I.S. Robertson and M.G. Nicholls. Gower Medical Publishing, London, 1993. Vol I, Chapter 26, p 1-43	1993
Coleman TG, Hall JE. Regional Blood Flow Regulation. In: Primer on Hypertension, American Heart Associaton Eds. J.L. Izzo, Jr. and H.C. Black. 1993. p 79-82	1993
Coleman TG, Hall JE. A Mathematicl Model of Renal Hemdynamics and Excretory Function. In: Computer Modeling of Comples Biological Systems. Vol. 11, (Ed.) Ed. Sl. Iyengary. CRC Press, 1992, p. 89-124	1992
Hall JE, Guyton AC. The Kidney and Blood Pressure Regulation. In: Renovascular and Renal Parenchymatos Hypertension: Pathophysiology Diagnosis and Management Eds.: T.F. Luscher and N.M. Kaplan. Springer-Verlag Publishers, Berlin, 1992. p. 3-29	1992
Hall JE, Brands MW. The Renin-Angiotensin-Aldosterone System: Renal Mechanisms and Circulatory Homeostasis. In: The Kidney: Physiology and Pathophysiology, 2nd Edition Eds. D.W. Seldin and G. Giebisch. Raven Press, New York, 1992. p 1455-1504	1992
Hall JE, Guyton AC. Control of Sodium Excretion and Arterial Pressure by Intrarenal Mechanisms and the Renin-Angiotensin System. In: Hypertension: Pathophysiology, Diagnosis and Management Eds. J.H. Laragh, B.M. Brenner. Raven Press Ltd., New York, 1990. p 1105-1130	1990
Guyton AC, Hall JE, Coleman TG, Manning Jr. RD. The Dominant Role of the Kidneys in the Long-Term Regulation of Arterial Pressure in Normal and Hypertensive States. In: Hypertension: Pathophysiology. Diagnosis and Management. Eds. J.H. Laragh and B.M. Brenner. Raven Press Ltd., New York, 1990. p 1029-1052	1990
Hall JE. Angiotensin Converting Enzyme Inhibition: Renal Effects and Their Role in Reducing Arterial Pressure. In: Current Advances in ACE Inhibitions Eds. G.A. McGregor and P. Sever. Churchill Livingston, London, 1989. pp 9-24	1989
Hall JE, Montani JP, Woods LL, Mizelle HL. Role of vasopressin and pressure diuresis in regulation of arterial pressure and body fluid volumes. Vasopressin, cellular and integrative functions Eds. A.W. Cowley Jr, J.F. Liard, D.A. Ausiello. Raven Press, New York, 1988. pp. 193-200	1988
Hall JE, Guyton AC, Coleman TG, Woods LL, Mizelle HL. Renal excretory function and hypertension. In: Perspectives in hypertension, Vol 1, The kidney in hypertension. Eds. B.M. Brenner and J.H. Laragh. Raven Press, New York, 1987. pp. 1-20.	1987
Petrini MF, Coleman TG, Hall JE. Basic Quantitative Concepts of Lung Function. The Lung. In: Mathematical Methods in Medicine, Part 2 Eds. D. Ingram and R. Bloch. John Wiley and Sons, New York, 1986. pp 295-336	1986
Coleman TG, Hall JE, Petrini MF. Basic Quantitative Concepts of the Circulating System. The Circulation. In: Mathematical Methods in Medicine, Part 2 Eds. D. Ingram, R. Bloch. John Wiley and Sons, New York, 1986. pp 175-195	1986
Hall JE. Role of Angiotensin and Aldosterone in Volume Homeostasis. In: Body Fluid Homeostasis. Contemporary Issues in Nephrology, Vol. 17 Eds. B.M. Brenner and J.H. Stein. Churchill Livingston, New York, 1986. p 69-100	1986
Hall JE, Coleman TG, Petrini MF. The Kidney. In: Mathematical Methods in Medicine, Part . Eds. D. Ingram and R. Bloch. Wiley Publishing Co., Ed. D. Ingram and R. Bloch. John Wiley and Sons, New York, 1986. pp. 427-471	1986
Hall JE, Montani JP. Role of the Kidney in Adrenocortical Induced Hypertension. In: The Adrenal Gland and Hypertension Eds. F. Mantero, E.G. Biglieri, J.W. Funder, B.A. Scoggins. Rave Press, New York, 1985, pp 185-208	1985
Guyton AC, Lohmeier TE, Hall JE, Smith MJ, Kastner PR. The Infinite Gain Principle for Arterial Pressure Control by the Kidney-Volume-Pressure System. In: Fundamental Fault in Hypertension Ed. M.P. Samishi. Martinus Nijhoff Publishers, Boston, 1984. p. 35-61	1984
Guyton AC, Manning RD, Lohmeier TE, Hall JE. The Kidney and Hypertension. In: Dopamine Receptor Agonists Ed. F.H. Messerli. Martinus Nijhoff Publishing, Boston, 1984. p. 87-103	1984
Guyton AC, Hall JE, Lohmeier TE, Manning Jr RD, Jackson TE, Kastner PR, Pan YJ. Role of the Kidney and Volume Control in the Pathogenesis of Hypertension. In: Handbook of Hypertension. Eds. W.H. Birkenhager and J.L. Reid. Vol. 1: Clinical Aspects of Essential Hypertension. Ed. J.I.S. Robertson. Elsevier, Amsterdam, 1983. pp. 216-238.	1983
Young DB, Pan Y, Hall JE, Lohmeier TE. Importance of Antinatriuretic Eeffects of Angiotensin and Aldosterone in Hypertension. In: Salt and Cardiovascular Hypertension Eds. M.J. Fregley and M.R. Kare. Academic Press, Philadelphia, 1982. pp. 247-265	1982
Hall JE. Regulation of Renal Hemodynamics. In: International Review of Physiology. Cardiovascular Physiology IV, Volume 26 Ed. A.C. Guyton and J.E. Hall. University Park Press, Baltimore, 1982. pp. 243-321	1982
Coleman TG, Hall JE, Norman Jr. RA. Regulation of Arterial Blood Pressure. In: Hypertension. Contemporary Issues in Nephrology. Vol. 8 Eds. B.M. Brenner and J.H. Stein. Churchill Livingston, New York, 1981. pp. 1-20	1981
Guyton AC, Hall JE, Lohmeier TE, Manning Jr RD, Jackson TE. The Concept of Whole Body Autoregulation and the Dominant Role of the Kidneys for Long-Term Blood Pressure Regulation. In: Frontiers in Hypertension Research Eds. J.H. Laragh, F.R. Buhler, D.W. Seldin. Springer-Verlag, New York, 1981. p 125-134	1981
Coleman TG, Manning RD, Norman Jr. RA, Samar RE, Hall JE, Guyton AC. Experimental Renoprival Hypertension. In: Hemodynamics of Arterial Hypertension Eds. C.M. Ferrario, M.N. Levy, R.C. Tarazi, C.V. Mosby. 1980	1980
Hall JE, Jackson TE, Guyton AC. Feedback Control of Intrarenal Function by the Renin-Angiotensin System. In: Arterial Pressure and Hypertension Eds. A.C. Guyton. W.B. Saunders Co., 1980. p 192-204	1980
Guyton AC, Hall JE, Norman Jr RA, Smith JR MJ, Balfe JW, Kastner PR. Physiology of Blood Pressure Regulation. In: Childhood Prevention of Atherosclerosis and Hypertension Eds. R.M. Lauer, R.B. Shekelle. Raven Press, New York, 1980. pp. 251-262	1980
Guyton AC, Hall JE, Lohmeier TE, Jackson TE. Modern Concepts of Circulatory Function. In Cardiology (International Congress Series 470) Eds. S. Hayase, S. Murao. Excerpta Medica, Amsterdam, 1979. pp.60-68	1979
Guyton AC, Hall JE, Manning Jr RD, Norman Jr RA, DeClue JW. A Systems Analysis of Volume Regulation. In Alfred Benzon Symposium XI, Osmotic and Volume Regulation. Munksgaard, Copenhagen, 1978 pp 283-296	1978
Guyton AC, Cowley Jr. AW, Young DB, Coleman TG, Hall JE, DeClue JW. Integration and control of circulatory function In: International Review of Physiology. Cardiovascular Physiology II. Eds. A.C. Guyton and A.W. Cowley Jr. University Park Press, Baltimore, 1976. pp 341-385	1976
Guyton AC, Young DB, DeClue JW, Ferguson JD, McCaa RE, Cevese A, Trippodo NC, Hall JE. The Role of the Kidney in Hypertension In: Pathophysiology and Management of Arterial Hypertension. Eds. G. Berglund, L. Hansoon, and L. Werko. A. Lindgren and Soner A.B., Molndal, Sweden, 1975. pp 78-89	1975
Book
Hall, JE Guyton and Hall Textbook of Medical Physiology, 13th Edition Elsevier Saunders, Philadelphia, 2016	2016
Hall, JE Guyton and Hall Physiology Review, 3rd edition Elsevier Saunders, Philadelphia, 2016	2016
Hall, JE Pocket Companion for Guyton and Hall Textbook of Medical Physiology Elsevier Saunders, Philadelphia, 5th Edition, 2016	2016
Hall JE Guyton and Hall Physiology Review, 2nd edition Elsevier Saunders, Philadelphia, 2011	2011
Hall JE Pocket Companion for Guyton and Hall Textbook of Medical Physiology Elsevier Saunders, Philadelphia, 4th Edition, 2011	2011
Hall, JE Guyton and Hall Textbook of Medical Physiology, 12th Edition Elsevier Saunders, Philadelphia, 2011	2011
Lip GYP, Hall JE (eds.). Comprehensive Hypertension Elsevier, New York, 2007	2007
Hall JE. Guyton and Hall Physiology Review Elsevier Saunders, Philadelphia, 2006	2006
Hall JE (ed.). Pocket Companion for Textbook of Medical Physiology, Guyton and Hall Elsevier Saunders, Philadelphia, 3rd Edition, 2006	2006
Guyton AC, Hall JE (ed.). Textbook of Medical Physiology, 11th Edition Elsevier Saunders, Philadelphia, 2006	2006
Hall JE, Adair TH. Rypins' Questions and Answers for Basic Sciences Review - Physiology, 4th Ed., ed. E.D. Frohlich J.B.Lippincott Co., Philadelphia, 2001	2001
Hall JE, Adair TH. Rypins’ Basic Sciences Review - Physiology, 18th Ed., ed. E.D. Frohlich J.B. Lippincott Co., Philadelphia, 2001	2001
Hall JE (ed.). Pocket Companion for Textbook of Medical Physiology, Guyton and Hall, 2nd edition W.B. Saunders Co., Philadelphia, 2000	2000
Guyton AC, Hall JE. Textbook of Medical Physiology, 10th Edition W. B. Saunders Co., Philadelphia, 2000	2000
Guyton AC, Hall JE. Human Physiology and Mechanisms of Disease, 6th Edition W.B. Saunders Co., Philadelphia, 1997	1997
Hall JE, Adair TH. Physiology. Rypins’ Intensive Reviews Lippincott - Raven, Philadelphia, 1997	1997
Hall JE (ed.). Pocket Companion for Textbook of Medical Physiology, Guyton and Hall W.B. Saunders Co., Philadelphia, 1997	1997
Hall JE, Adair TH. Rypins’ Basic Sciences Review - Physiology, 17th Ed., ed. E.D. Frohlich J.B. Lippincott Co., Philadelphia, 1997	1997
Hall JE, Adair TH. Rypins’ Questions and Answers for Basic Sciences Review - Physiology, 3rd Ed., ed. E.D. Frohlich J.B.Lippincott Co., Philadelphia, 1997	1997
Guyton AC, Hall JE. Textbook of Medical Physiology, 9th Edition W.B. Saunders Co., Philadelphia, 1996	1996
Guyton AC, Hall JE. Cardiovascular Physiology IV, International Review of Physiology University Park Press, Baltimore, 1982	1982
Editorial Commentary
Jones DW, Hall JE. JNC-7 and evidence from new hypertension trials Hypertension. 2004; 43:1-3	2003
Hall JE. The renin-angiotensin system and control of renal function: historical perspective In: One Hundred Years of the Renin-Angiotensin System: Past Accomplishments and Future Prospects. Ed. M.G. Nichols., H.R. Brunner, H. Ikram, C.S. Sweet, and J.F. Walker. p.21-26, 1998	1998
Hall JE. Speculation on regulatory, integrative and comparative physiology (the Journal) Am J Physiol. 1996; 270:R1-R2	1996
Brands MW, Hall JE. Hyperinsulinemia and hypertension Nutr Metab Cardiovasc Dis. 1994; 3:155-157	1994
Letter to the Editor
Pickering TG. Hall JE, Appel L, Falkner B, Graves J, Hill M, Jones DW, Kurtz T, Sheps S, Roccella E. Response to recommendations for blood pressure measurement in human and experimental animals; Part 1: Blood pressure measurement in humans and miscuffing: A problem with new guidelines Hypertension. 2006; 48:e5-e6	2006
Skek EW, Hall JE, Brands MW. Leptin and the renin-angiotensin-aldosterone system Hypertension. 1998; 32:376	1998

Presentations

National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity and Metabolic Syndrome, First Caribbean Obesity Summit: Diabetes & Obesity; Second Scientific Meeting of the American Physiological Society, Puerto Rico Chapter, Ponce, Puerto Rico	03/2012
Invited Symposia, Hypertension From Bench to Bedside: A Tale of Mice and Men, André Aisenstadt Memorial Clinical Day, Jewish General Hospital, Montreal, Canada	10/2011
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Physiology of Cardiovascular Disease: Gender Disparities, American Physiological Society, Jackson, MS	10/2011
National and International Invited Seminars/Lectures, Central Role of Obesity in Hypertension and Cardiometabolic Disease, American Heart Association Council for High Blood Pressure Research, Orlando, FL	09/2011
Invited Symposia, 38th Annual Pharmacology Research Colloquium and the Department of Physiology and Pharmacology 2nd Students Research Forum, University of Toledo Health Sciences Campus, Toledo, OH	06/2011
National and International Invited Seminars/Lectures, Role of Aldosterone and Mineralocorticoid Receptor Activation in Obesity Related Hypertension, American Society of Hypertension, New York, NY	05/2011
National and International Invited Seminars/Lectures, Obesity-Related Hypertension: Basic Concepts and Clinical Implications, American Society of Hypertension, New York, NY	05/2011
National and International Invited Seminars/Lectures, Hypertension in Obesity/Metabolic Syndrome: Basic Concepts and Clinical Implications, Yangtze River International Congress of Cardiology, Chongqing City, China	04/2011
National and International Invited Seminars/Lectures, Mechanisms of Salt-Sensitive Hypertension and Target Organ Injury, Yantze River International Congress of Cardiology, Chongqing City, China	04/2011
Visiting Professor, Visiting Professor, Third Medical University, Chongqing City, China	04/2011
Invited Symposia, Leptin, obesity and hypertension: Understanding the key mechanisms, International Society of Nephrology, Vancouver, British Columbia, Canada	04/2011
National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Indiana Physiological Society Meeting, Indianapolis, Indiana	02/2011
Scientific Presentations, Methodological Issues in Collecting Urinary Sodium in NHANES, National Heart, Lung and Blood Institute, Bethesda, MD	01/2011
Invited Symposia, Obesity – A Growing Threat to our Health & Economy, Singing River Health System, Biloxi, MS	11/2010
National and International Invited Seminars/Lectures, Obesity Hpertension and Renal Hemodynamics, FASEB Summer Research Conference on "Renal Hemodynamics: Mechanisms to Understand Disease, Saxton River, VT	06/2010
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, University of Alberta Cardiovascular Centre, Edmonton, Canada	06/2010
National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, University of Missouri-Columbia, Columbia, Missouri	05/2010
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Department of Physiology and Pharmacology, Department of Medicine Grands Rounds,University of Toledo College of Medicine, Toledo, Ohio	05/2010
Invited Symposia, Renal Function and the Law of Starling, Symposium on “One Hundred Years of Starling: his Contributions to Physiology", Experimental Biology 2010, American Physiological Society, Anaheim, California	04/2010
National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Hypertension Symposium, Boston University School of Medicine, Boston, MA	04/2010
Scientific Presentations, Pathophysiology of Obesity Hypertension, Merck & Co, Cardiovascular Diseases Division, Rahway, NJ	10/2009
National and International Invited Seminars/Lectures, Pathophysiology of Obesity/Metabolic Syndrome, Michigan State University, Department of Toxicology, East Lansing, MI	10/2009
Scientific Presentations, Session on “Meet the Expert”, XV Scientific Sessions of the Inter-American Society of Hytpertension, Inter-American Society of hypertension, Belo Horizonte, Brazil	08/2009
National and International Invited Seminars/Lectures, Plenary lecture, XV Scientific Sessions of the Inter-American Society of Hytpertension-"Hypertension and Obesity", Inter-American Society of Hypertension, Belo Horizonte, Brazil	08/2009
National and International Invited Seminars/Lectures, Meet the Expert Session on Obesity Hytension- What the Hypertension Specialist Know about Experimental Hypertension and Obesity, American Society of Hypertension, San Francisco, CA	05/2009
National and International Invited Seminars/Lectures, Pathobiology of Obesity- What the Hypertension Specialist know about Experimental Hypertension and Obesity, American Society of Hypertension, San Francisco, CA	05/2009
Invited Symposia, Pathophysiology of hypertension in obesity/metabolic syndrome, University of Arkansas Medical School, Department of Pharmacology and Toxicology, Little Rock, AR	04/2009
National and International Invited Seminars/Lectures, Pathophysiology of hypertension in obesity/metabolic syndrome, University of Utah, Department of Medicine, Division of Nephrology, Salt Lake City, Utah	04/2009
National and International Invited Seminars/Lectures, Hypothalamic melanocortins, sympathetic activation, and obesity hypertension, Palatin Technologies, Inc, Princeton, New Jersey	02/2009
Invited Symposia, Invited Speaker, Medical Student Research Day, Medical Student Research Day, University of Alabama-Birmingham, Birmingham, Alabama	11/2008
Regional Invited Seminars/Lectures, Pathophysiology of hypertension in obesity/metabolic syndrome: Role of adipokines, Department of Physiology & Biophysics, University of Alabama-Birmingham, Birmingham, AL	11/2008
National and International Invited Seminars/Lectures, Obesity, Hypertension and Renal Hemodynamics, International Society of Nephrology Nexus Symposium, Diabetes and the Kidney, Dublin, Ireland	06/2008
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Department of Medicine, University of Texas Health Science Center, San Antonio, TX	05/2008
Invited Symposia, The Kidney: Aging, Apoptosis, Endocrine Sensitivity and the Kidney’s Role in Hypertension, Experimental Biology 2008, San Diego, CA	04/2008
National and International Invited Seminars/Lectures, Hypertension and the Kidney, International Society of Nephrology Nexus Symposium, Hypertension and the Kidney, Vienna, Austria	11/2007
National and International Invited Seminars/Lectures, Mechanisms of Hypertension in Obesity/Metabolic Syndrome, Canadian Hypertension Society 28th Annual Meeting, Quebec City, Canada	10/2007
Invited Symposia, Pathophysiology of hypertension in obesity/metabolic syndrome, Department of Physiology, University of Maryland, Baltimore, MD	05/2007
National and International Invited Seminars/Lectures, Obesity, Adipokines and Hypertension, 17th Meeting of Inter-American Society of Hypertension, Miami, FL	05/2007
Invited Symposia, Invited Lecture, Clinical Nutrition Research Center, University of Alabama-Birmingham, Birmingham, AL	03/2007
Invited Symposia, CVI Seminar, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA	02/2007
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Tulane University School of Medicine, New Orleans, LA	11/2006
Meet the Professor, Cardiovascular Complications of Obesity, 3rd Endocrinology Canada International Symposium, Toronto, Canada	11/2006
Invited Symposia, Pathology of Hypertension in Obesity/Metabolic Syndrome, 3rd Endocrinology Canada International Symposium, Toronto, Canada	11/2006
Invited Symposia, Pathophysiology of Obesity Hypertension: Neurohumoral and Renal Mechanisms, Department of Medicine, Nephrology Grand Rounds, University of Virginia, Charlottesville, VA	11/2006
Invited Symposia, Distinguished Lecturer, Department of Physiology, Anatomy and Genetics, Oxford University, Oxford, England, United Kingdom	11/2006
National and International Invited Seminars/Lectures, Role of the Renin-Angiotensin Aldosterone System, Keynote Lecture at International Symposium, Sendai, Japan	10/2006
National and International Invited Seminars/Lectures, Salt, Kidney and Hypertension, Keynote Lecture at International Symposium, Nagoya, Japan	10/2006
National and International Invited Seminars/Lectures, Adipokines, Obesity and Hypertension, International Society of Hypertension, Fukuoka, Japan	10/2006
Invited Symposia, Invited Professor-"Pathophysiology of Hypertension in Obesity/Metabolic Syndrome", Nephrology Division and Department of Physiology, University of Florida, Gainesville, FL	08/2006
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Merck & Co., Cardiovascular Diseases Division, Rahway, NJ	06/2006
National and International Invited Seminars/Lectures, Obesity and Hypertension: Role of the renin-angiotensin- aldosterone system, Novartis Institutes for Biomedical Research, East Hanover, NJ	06/2006
Invited Symposia, Nephrology and Hypertension Grand Rounds-"Metabolic Syndrome, Hypertension, and Cardiovascular-Renal Disease", Mayo Clinic College of Medicine, Rochester, MN	04/2006
Invited Symposia, Research Forum-Neurohumoral and Renal Mechanisms of Obesity Hypertension, Mayo Clinic College of Medicine, Rochester, MN	04/2006
Scientific Presentations, Obesity and Renal Disease, Experimental Biology 2006, San Francisco, CA	04/2006
Scientific Presentations, Melanocyte Stimulating Hormones and Their Receptors, Experimental Biology 2006, San Francisco, CA	04/2006
Scientific Presentations, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Eli Lilly Research Laboratories “Endocrine Think Tank”, Indianapolis, IN	11/2005
Invited Symposia, Invited Lecture, Georgetown University Medical Center, Cardiovascular-Kidney Institute, Washington, DC	10/2005
National and International Invited Seminars/Lectures, Obesity and metabolic syndrome, Inter-American Society of Hypertension Symposium, Cancun, Mexico	04/2005
Invited Symposia, Vascular regulatory abnormalities in obesity, Microcirculatory Society's President's Symposium, San Diego, California	04/2005
Invited Symposia, Hypertension and metabolic syndrome, Pfizer, St. Louis, Missouri	01/2005
State/Local Invited Seminars/Lectures, A. Ross McIntyre Memorial Lecture, University of Nebraska Medical Center, Omaha, Nebraska	2005
National and International Invited Seminars/Lectures, Hypertension Summer School, American Heart Association, Castine, Maine	2005
Regional Invited Seminars/Lectures, Keynote Speaker at Regional Hypertension Workshop, Kellogg Biological Station, Michigan	2005
National and International Invited Seminars/Lectures, Workshop on "Emerging Concepts on Neural Intractions in Hypertension", American Heart Association, Council for High Blood Pressure Research, Washington, D.C.	2005
Invited Symposia, Renal mechanisms of salt sensitive hypertension, American Society of Hypertension, New York, NY	05/2004
National and International Invited Seminars/Lectures, Mechanisms of obesity hypertension, 20th Scientific Meeting of the International Society of Hypertension, Sao Paulo, Brazil	02/2004
Invited Symposia, Arthur C. Guyton: the Man and His Science, Experimental Biology, Washington, D.C.	2004
Invited Symposia, Cardiovascular Injury and the Renin-Angiotensin System, Takeda Pharmaceuticals, New Orleans, Louisiana	2004
Visiting Professor, Invited Lecture, Eastern Virginia Medical School, Department of Physiology	2004
State/Local Invited Seminars/Lectures, Invited Lecture, Pfizer Global Research & Development, St. Louis, Missouri	2004
State/Local Invited Seminars/Lectures, Invited Lecture, Louisiana State University, Department of Physiology, New Orleans, Louisiana	2004
Visiting Professor, Invited Lecture, Medical College of Georgia, Deparment of Physiology, Augusta, Georgia	2004
National and International Invited Seminars/Lectures, Keynote Lecture, The Society of Nephrology and Hypertension of Puerto Rico, San Juan, Puerto Rico	2004
National and International Invited Seminars/Lectures, Keynote Lecture, The 4th Annual Meeting of The Safety Pharmacology Society, Cincinnati, Ohio	2004
State/Local Invited Seminars/Lectures, Medicine Grand Rounds Lecture at "E. Eric Muirhead Hypertension Research Day", The University of Tennessee Health Sciences Center, Memphis, Tennessee	2004
National and International Invited Seminars/Lectures, Renal Microcirculatory and Tubular Dynamics: Molecules to Man, FASEB Summer Conference, Pine Mountain, Georgia	2004
State/Local Invited Seminars/Lectures, Invited Lecture, Merck, Sharpe & Dohme Obesity Research Group, Rahway, New Jersey	2003
Visiting Professor, Invited Lecture, Wake Forest University, Bowman Gray School of Medicine, Hypertension and Vascular Disease Center, Winston Salem, North Carolina	2003
National and International Invited Seminars/Lectures, Invited Lecture, 5th European Federation of Autonomic Societies Meeting, Toulouse, France	2003
National and International Invited Seminars/Lectures, Invited Lecture, International Conference on Mediterranean Cardiovascular Risk, Murcia, Spain	2003
State/Local Invited Seminars/Lectures, Invited Lecture, Medical College of Wisconsin, Department of Physiology	2003
Invited Symposia, New Frontiers in Cardiovascular Disease Management, San Antonio, Texas	2003
Regional Invited Seminars/Lectures, Plenary Session on "Syndrome X- Fact or Fiction", Southern Society for Clinical Investigation, New Orleans, Louisiana	2003
National and International Invited Seminars/Lectures, Symposium in honor of Arthur C. Guyton, Biomedical Engineering Society, Nashville, Tennessee	2003
State/Local Invited Seminars/Lectures, Symposium on "Obesity: Complications and Treatment", University of Houston, Heart and Kidney Institute	2003
Invited Symposia, The Last 10 Years in Cardiovascular Disease Management, Wake Forest University School of Medicine, Winston Salem, North Carolina	2003
National and International Invited Seminars/Lectures, Workshop on "The Insulin Resistance Syndrome and the Pathophysiology of Hypertension, Cardiovascular and Renal Disease", Council for High Blood Pressure Research Workshop, Washington, D.C.	2003
National and International Invited Seminars/Lectures, Conference Magna Lecture on "Obesity, Hypertension and Kidney Disease- the Last Frontier of Prevention", Brazilian Society of Hypertension, Porto Alegre, Brazil	2002
National and International Invited Seminars/Lectures, Hypertension and the Plurimetabolic Syndrome, Brazilian Society of Hypertension, Porto Alegre, Brazil	2002
State/Local Invited Seminars/Lectures, Keynote Lecture, Hypertension and Related Disorders Meeting, Sydney, Australia	2002
State/Local Invited Seminars/Lectures, Mechanisms of Hypertension and Renal Disease in the Metabolic Syndrome, GlaxoSmith Kline Pharmaceuticals Co., Philadelphia, Pennsylvania	2002
State/Local Invited Seminars/Lectures, Medical Grand Rounds, University of Puerto Rico School of Medicine, San Juan, Puerto Rico	2002
State/Local Invited Seminars/Lectures, Medical Grand Rounds, Veterans Administration Hospital, University of Puerto Rico School of Medicine, San Juan, Puerto Rico	2002
Visiting Professor, Nephrology Grand Rounds, Thomas Jefferson Medical College, Philadelphia, Pennsylvania	2002
National and International Invited Seminars/Lectures, Novartis Award Lecture, American Heart Association, Council for High Blood Pressure Research	2002
National and International Invited Seminars/Lectures, Obesity, Hypertension and Kidney Disease, Kyushu University, Fukuoka, Japan	2002
National and International Invited Seminars/Lectures, Physiological Approach to Hypertension Research: Role of the Kidney, 25th Meeting of Japanese Society of Hypertension, Tokyo, Japan	2002
National and International Invited Seminars/Lectures, Symposium on "Blood Pressure Control in Cardiovascular Disease Prevention", Japanese Society of Hypertension, Tokyo, Japan	2002
National and International Invited Seminars/Lectures, Symposium on "Hypertension and Diabetes: The Emerging Epidemic", American Heart Association, 75th Scientific Sessions, Chicago, Illinois	2002
National and International Invited Seminars/Lectures, Symposium on "Obesity and Cardiovascular Disease", American Heart Association, 75th Scientific Sessions, Chicago, Illinois	2002
National and International Invited Seminars/Lectures, The Metabolic Syndrome and Hypertension: The Next Frontier of Prevention and Treatment of Cardiovascular Disease, Tokyo Medical University, Tokyo, Japan	2002
Invited Symposia, Vascular Biology and Hypertension Research Symposium, Destin, Florida	2002
National and International Invited Seminars/Lectures, Experimental Models of Obesity and Hypertension, XIV Meeting of the Inter-American Society of Hypertension, Santiago, Chile	2001
Visiting Professor, Invited Lecture, Indiana University School of Medicine, Indianapolis, Indiana	2001
Burroughs Wellcome Visiting Professor, Invited Lecture, University of North Dakota School of Medicine, Vermillion, North Dakota	2001
Visiting Professor, Invited Lecture, University of North Carolina, Department of Cell and Molecular Physiology, Chapel Hill, North Carolina	2001
Visiting Professor, Invited Lecture, Department of Internal Medicine and Cardiovascular Research Institute, University of North Dakota, Sioux Falls, North Dakota	2001
Visiting Professor, Invited Lecture, University of Kentucky, School of Pharmacy and School of Medicine	2001
National and International Invited Seminars/Lectures, Invited Lecture, International Society of Obesity Hypertension, Berlin, Germany	2001
National and International Invited Seminars/Lectures, Obesity , the Renin-Angiotensin System, and Renal Damage in the Hypertensive Patient, Spanish Hypertension Society, Malaga, Spain	2001
National and International Invited Seminars/Lectures, Role of Leptin and Sympathetic Nervous System in Hypertension, International Pediatric Hypertension Association, San Francisco, California	2001
Regional Invited Seminars/Lectures, Symposium on "Obesity-Associated Hypertension: Pathophysiology and Treatment", Consortium for Southeastern Hypertension Control, Charleston, South Carolina	2001
National and International Invited Seminars/Lectures, Vertical Integration of Physiology in the Medical School Curriculum, Association of Charis of Departments of Physiology, Los Cabos, Mexico	2001
National and International Invited Seminars/Lectures, Workshop on the "Pathophysiology of Obesity- Associated Cardiovascular Disease", National Heart, Lung and Blood Institute, Bethesda, Maryland	2001
Regional Invited Seminars/Lectures, Hypertension and Cardiovascular Disease in ESRD, Southeastern Dialysis and Transplantation Association, Biloxi, Mississippi	2000
National and International Invited Seminars/Lectures, Hypertension and the New Biology of Obesity, 1st John H. Laragh Conference on Advances in Hypertension Research, Boca Raton, Florida	2000
Visiting Professor, Invited Lecture, Louisiana State University Medical Center, Shreveport, Louisiana	2000
Visiting Professor, Invited Lecture, Georgetown University Medical Center, Washington, D.C.	2000
Visiting Professor, Invited Lecture, University of Houston, Department of Physiology and Pharmaceutical Sciences, Houston, Texas	2000
National and International Invited Seminars/Lectures, Mechanisms of Obesity Hypertension and Renal Disease, Cardiovascular Research Division, Searle Pharmaceuticals, St. Louis, Missouri	2000
National and International Invited Seminars/Lectures, Obesity Hypertension, Spanish Society of Hypertension, Madrid, Spain	2000
National and International Invited Seminars/Lectures, Richard Bright Award Lecture on "Obesity, Hypertension, and Kidney Disease", 15th Scientific Meeting of the American Society of Hypertension, New York, New York	2000
National and International Invited Seminars/Lectures, State of the Art Lecture on "Mechanisms of Obesity Hypertension and Relevance to Essential Hypertension", International Society of Hypertension, Chicago, Illinois	2000
National and International Invited Seminars/Lectures, Basic Science Review of Salt Intake and Cardiovascular Disease, American Society of Hypertension, New York, New York	1999
State/Local Invited Seminars/Lectures, Distinguished Lecturer, Hypertension Research Center, University of Medicine and Dentistry of New Jersey, Newark, New Jersey	1999
National and International Invited Seminars/Lectures, Integration and Regulation of Cardiovascular Function, The APS, Experimental Biology, Washington, D.C.	1999
Visiting Professor, Invited Lecture, Colorado State University, Ft. Collins, Colorado	1999
Visiting Professor, Invited Lecture, University of Alabama- Birmingham School of Medicine, Department of Physiology	1999
National and International Invited Seminars/Lectures, Mechanisms of Obesity-Related Hypertension, Local vs. Circulating Angiotensin II: Are They Both Involved in Hypertension?, AHA, Third Hypertension Summer School, Boulder, Colorado	1999
National and International Invited Seminars/Lectures, Obesity, Hypertension, and End-Stage Renal Disease, XIIIth Meeting of Inter-American Society of Hypertension, Buenos Aires, Argentina	1999
National and International Invited Seminars/Lectures, Obesity: Impact on Cardiovascular Disease, American College of Cardiology, 48th Annual Sessions, New Orleans, Louisiana	1999
National and International Invited Seminars/Lectures, Renal Mechanisms of Obesity Hypertension, International Symposium on Obesity and Hypertension, Berlin, Germany	1999
National and International Invited Seminars/Lectures, Role of Neuropeptides and the Sympathetic Nervous System in Obesity Hypertension, III International Symposium on Vasoactive Peptides, Belo Horizonte, Brazil	1999
National and International Invited Seminars/Lectures, Role of Obesity in Hypertension and End-Stage Renal Disease, Congresso da Sociedade Brasileira de Hipertensao, Rio de Janeiro, Brazil	1999
National and International Invited Seminars/Lectures, The Metabolic Syndrome X: Convergence of Insulin Resistance, Hypertension, Obesity, and Dyslipidemias, New York Academy of Sciences, Jacksonville, Florida	1999
Workshop, Workshop on Sodium and Blood Pressure, National Heart, Lung, and Blood Institute, Bethesda, Maryland	1999
National and International Invited Seminars/Lectures, 100 Years of the Renin-Angiotensin System: Past Accomplishments and Future Prospects, International Symposium, Rome, Italy	1998
National and International Invited Seminars/Lectures, Angiotensin Receptor Blockade and the Kidney, American Society of Nephrology, Philadelphia, Pennsylvania	1998
National and International Invited Seminars/Lectures, Cardiovascular and Renal Pathophysiology of Obesity, VII Congress of Brazilian Society of Hypertension, Goiania, Brazil	1998
National and International Invited Seminars/Lectures, Ernest G. Starling Distinguished Lecture, The American Physiological Society, Experimental Biology, San Francisco, California	1998
Visiting Professor, Invited Lecture, Rush-Presbyterian- St. Luke's Medical Center, Rush University, Chicago, Illinois	1998
Visiting Professor, Invited Lecture, Heart Institute, Universidade de Sao Paulo, Brazil	1998
Visiting Professor, Invited Lecture, Physiology Department, Faculdade de Medicina de Ribeiro Preto, Da Universidade de Sao Paulo, Brazil	1998
Visiting Scientist, Invited Lecture, Merck, Sharp and Dohme Research Laboratories, West Point, Pennsylvania	1998
National and International Invited Seminars/Lectures, Is Obesity the Culprit in Causing Excess Hypertension and End-Stage Renal Disease in African-Americans?, Third Congress on Treatment of Cardiovascular Diseases in African-Americans, Dallas, Texas	1998
State/Local Invited Seminars/Lectures, Keynote Lecture, 75th Anniversary of Physiology Department, Michigan State University, East Lansing, Michigan	1998
National and International Invited Seminars/Lectures, Keynote Lecture, 4th Meeting on the Kidney and Hypertension, Tokyo, Japan	1998
National and International Invited Seminars/Lectures, Mechanisms of Renal Dysfunction in Obesity and Role in Hypertension, American Society of Hypertension, New York, New York	1998
State/Local Invited Seminars/Lectures, Obesity and Hypertension, Mississippi Academy of Sciences	1998
National and International Invited Seminars/Lectures, Obesity: Impact on Cardiovascular Disease, American Heart Association, Amelia Island, Florida	1998
State/Local Invited Seminars/Lectures, Pfizer Lecture, Clinical Research Institute of Montreal, Montreal, Canada	1998
National and International Invited Seminars/Lectures, Salt, Hypertension and the Pathophysiology of Cardiovascular Disease, University of Tokyo, Tokyo, Japan	1998
National and International Invited Seminars/Lectures, Sodium: To Restrict or Not to Restrict For the Hypertensive Patient, 7th Annual National Kidney Foundation Meeting, Nashville, Tennessee	1998
State/Local Invited Seminars/Lectures, Why Is There So Much Cardiovascular Disease in Mississippi, Tougaloo College, Jackson, Mississippi	1998
National and International Invited Seminars/Lectures, Abnormal Kidney Function as a Cause and Consequence of Obesity Hypertension, Experimental Biology, New Orleans, Louisiana	1997
National and International Invited Seminars/Lectures, Cardiovascular and Renal Pathophysiology of Obesity, American Society of Hypertension, San Francisco, California	1997
National and International Invited Seminars/Lectures, Cardiovascular and Renal Pathophysiology of Obesity, and Relevance to Essential Hypertension, Astra-Hassle, Gothenberg, Sweden	1997
National and International Invited Seminars/Lectures, Insulin Resistance and Obesity, and Their Role in Cardiovascular and Renal Disease, American Society of Nephrology, Clinical Sciences Symposium, San Antonio, Texas	1997
National and International Invited Seminars/Lectures, Intrarenal Actions of Angiotensin II and Long-Term Blood Pressure Regulation, International Centenary Symposium in Honor of Robert Tigerstedt, Stockholm, Sweden	1997
Visiting Professor, Invited Lecture, Hypertension Center, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina	1997
National and International Invited Seminars/Lectures, Obesity, Insulin Resistance and Cardiovascular Disease, International Symposium on Hypertension, Seville, Spain	1997
National and International Invited Seminars/Lectures, Renal Mechanism of Obesity Hypertension and Relevance to Essential Hypertension, XXXIII International Congress of Physiological Sciences, St. Petersburg, Russia	1997
National and International Invited Seminars/Lectures, Resistance to Metabolic Actions of Insulin and Cardiovascular Disease, Inter-American Society of Hypertension, Mexico City, Mexico	1997
National and International Invited Seminars/Lectures, Salt-Sensitivie Hypertension and Vascular Disease, International Symposium on Hypertension, Seville, Spain	1997
National and International Invited Seminars/Lectures, Advances in the Genetics and Therapy of Obesity: Cardiovascular Implications, American Heart Association Annual Meeting	1996
National and International Invited Seminars/Lectures, Insulin Resistance and its Role in Cardiovascular Disease, Fourth Congress of Argentine Society of Hypertension, Buenos Aires, Argentina	1996
National and International Invited Seminars/Lectures, Resistance to Metabolic Actions of Insulin and Hypertension, Hypertension Society of Mexico, Mexico City, Mexico	1996
Regional Invited Seminars/Lectures, Salt, Vascular Injury, and Hypertension, Consortium of Southeastern Hypertension Centers, Raleigh, North Carolina	1996
National and International Invited Seminars/Lectures, Salt-Sensitive Hypertension, Fourth Congress of Argentine Society of Hypertension, Buenos Aires, Argentina	1996
National and International Invited Seminars/Lectures, Career Opportunities in the Medical School Basic Science Departments, Experimental Biology 1995, Atlanta, Georgia	1995
National and International Invited Seminars/Lectures, Hypertension: Causes and Consequences of Renal Injury, Barcelona, Spain	1995
Invited Symposia, Insulin Resistance and Hypertension, Philadelphia, Pennsylvania	1995
National and International Invited Seminars/Lectures, Insulin Resistance and Hypertension in the Elderly, 3rd International Congress on Hypertension in the Elderly, Rome, Italy	1995
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Tennessee, Memphis, Tennessee	1995
National and International Invited Seminars/Lectures, Mechanisms of Obesity Associated Hypertension and Relevance to Essential Hypertension, International Congress of Nephrology, Madrid, Spain	1995
National and International Invited Seminars/Lectures, Mechanisms of Obesity Hypertension and Their Relevance to Human Essential Hypertension, London Cardiovascular Society, London, Ontario, Canada	1995
National and International Invited Seminars/Lectures, Obesity and Hypertension, Brookhaven National Laboratory, Montreal, Canada	1995
National and International Invited Seminars/Lectures, Obesity, Insulin Resistance and Hypertension, North American Society for the Study of Obesity Annual Meeting, Baton Rouge, Louisiana	1995
National and International Invited Seminars/Lectures, Pathophysiological Aspects of the Relationship Between Hypertension and Obesity, Spanish Society for Hypertension, Madrid, Spain	1995
State/Local Invited Seminars/Lectures, Pathophysiology of Obesity Hypertension, Amylin Pharmaceuticals, Inc., San Diego, California	1995
Regional Invited Seminars/Lectures, Physiological Mechanisms of Salt Sensitivity, Consortium of Southeastern Hypertension Centers, 2nd Annual Meeting, Charleston, South Carolina	1995
National and International Invited Seminars/Lectures, Renal Mechanisms of Hypertension: Role of Obesity and Sodium, Brookhaven National Laboratory, New York, New York	1995
State/Local Invited Seminars/Lectures, The Renin-Angiotensin System: Normal Physiology and Role in Hypertension, Symposium on "Angiotensin Receptor (ATI) Blockers", Jackson, MS	1995
Invited Symposia, Insulin Resistance Syndrome: Role in a Panoply of Disorders, The Endocrine Society, 76th Annual Meeting, Anaheim, California	1994
Invited Symposia, Insulin Resistance, Obesity, and Hypertension, Experimental Biology 1994, Anaheim, California	1994
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Missouri School of Medicine, Columbia, Missouri	1994
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Texas Health Sciences Center, San Antonio, Texas	1994
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Louisville, Louisville, Kentucky	1994
National and International Invited Seminars/Lectures, Neurohumoral and Renal Mechanisms of Obesity Hypertension, President's Symposium, American Society of Hypertension, New York, New York	1994
National and International Invited Seminars/Lectures, Obesity Hypertension, the Renal Mdulla and the Renal Nerves, Hypertension Investigators Meeting, Amelia Island, Florida	1994
Regional Invited Seminars/Lectures, The Kidney and Hypertension, Consortium of Southeastern Hypertension Centers Symposium, Asheville, North Carolina	1994
Regional Invited Seminars/Lectures, Cellular and Molecular Mechanisms in Atherosclerosis and Hypertension, Fourteenth Annual Meeting of the Southeastern Pharmacology Society, Memphis, Tennessee	1993
National and International Invited Seminars/Lectures, Insulin Resistance and Hypertension, Inter-American Society of Hypertension, San Diego, California	1993
National and International Invited Seminars/Lectures, Insulin Resistance and Sympathetic Activity in Arterial Hypertension, Spanish Foundation for Cardiovascular Research, Madrid, Spain	1993
Invited Symposia, International Symposium on ACE Inhibition, Amsterdam, the Netherlands	1993
National and International Invited Seminars/Lectures, Interrelationships between Hyperinsulinemia, Hypertension and Diabetes, Including its Renal and Vascular Complications, American Society of Hypertension, New York, New York	1993
State/Local Invited Seminars/Lectures, Invited Lecture, Parke-Davis Pharmaceutical Research, Cardiovascular Pharmacology Department, Ann Arbor, Michigan	1993
State/Local Invited Seminars/Lectures, Visiting Professor, Department of Nephrology, Utrecht University, Utrecht, the Netherlands	1993
State/Local Invited Seminars/Lectures, Visiting Professor, Department of Physiology, Tulane University, New Orleans, Louisiana	1993
State/Local Invited Seminars/Lectures, Visiting Professor, Department of Physiology, University of Murcia School of Medicine, Murcia, Spain	1993
State/Local Invited Seminars/Lectures, Hypertension in Theory and in Practice, Jackson, MS	1992
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Arkansas, Little Rock, Arkansas	1992
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Medical Physiology, Texas A&M University, College Station, Texas	1992
State/Local Invited Seminars/Lectures, John Whitney Memorial Medical Lecture, University of Arkansas Medical School, Little Rock, Arkansas	1992
National and International Invited Seminars/Lectures, Kidney Function and Hypertension, 29th Meeting of Japanese Society of Applied Physiology, Gifu, Japan	1992
National and International Invited Seminars/Lectures, Lewis K. Dahl Memorial Lecture, American Heart Association, New Orleans, Louisiana	1992
Forum, Nephrology Forum, Kidney International, Boston, Massachusetts	1992
National and International Invited Seminars/Lectures, Nephrology Research Conference, New England Medical Center, Tufts University, Boston, Massachusetts	1992
National and International Invited Seminars/Lectures, Obesity, Hyperinsulinemia and Hypertension, Hypertension Society of Mexico, State of the Art Lecture, Mexico City, Mexico	1992
Invited Symposia, Renal Excretory Function and Hypertension, Hypertension Investigators' Symposium, Amelia Island, Florida	1992
National and International Invited Seminars/Lectures, The Kidney in Hypertension, Hypertension Society of Mexico, Mexico City, Mexico	1992
National and International Invited Seminars/Lectures, Insulin and Hypertension, American Society of Hypertension, New York, New York	1991
State/Local Invited Seminars/Lectures, Invited Lecture, Bristol-Meyers Squibb Pharmaceutical Group, Princeton, New Jersey	1991
State/Local Invited Seminars/Lectures, Invited Lecture, The University of Iowa College of Medicine, Department of Internal Medicine, Iowa City, Iowa	1991
Invited Symposia, Mechanisms of Endocrine Hypertension, American Physiological Society, San Antonio, Texas	1991
Workshop, Nutrition and Hypertension, National Institutes of Health, Washington, DC	1991
National and International Invited Seminars/Lectures, Obesity and Hypertension, American Society of Nephrology, Baltimore, Maryland	1991
State/Local Invited Seminars/Lectures, The Kidney, Obesity and Essential Hypertension, Jackson, Mississippi	1991
Invited Symposia, Treatment Considerations in the Mature and Elderly Hypertensive Patient, West Penn Hospital, Pennsylvania	1991
Invited Symposia, ACE Inhibition in the 1990's, Napa, California	1990
State/Local Invited Seminars/Lectures, Invited Lecture, Merck, Sharp & Dohme Research Laboratories, West Point, Pennsylvania	1990
Invited Symposia, What is the Mechanism of One-Kidney, One-Clip Hypertension and its Relevance to Low-Renin Essential Hypertension?, American Society of Hypertension, New York, New York	1990
Invited Symposia, ACE Inhibition in the 1990's and Clinical Trial Results with the New Agent Benazepril, West Palm Beach, Florida	1989
National and International Invited Seminars/Lectures, Biological Responses to Prolonged Increase in Atrial Natriuretic Factor, Federation of American Societies of Experiemental Biology and Medicine, New Orleans, Louisiana	1989
Invited Symposia, International Symposium on ACE Inhibition, London, England	1989
State/Local Invited Seminars/Lectures, Invited Lecture, The Squibb Institute for Medical Research, Princeton, New Jersey	1989
State/Local Invited Seminars/Lectures, Invited Lecture, University of South Carolina, Division of Nephrology, Charleston, South Carolina	1989
State/Local Invited Seminars/Lectures, Invited Lecture, der Universitat Heidelberg, I. Physiologisches Institut, Heidelberg, Germany	1989
National and International Invited Seminars/Lectures, Mechanisms of Sodium Homeostasis, Copenhagen, Denmark	1989
National and International Invited Seminars/Lectures, Renal Hemodynamics: Integrative and Cellular Mechanisms, FASEB Summer Conference, Saxtons River, Vermont	1989
National and International Invited Seminars/Lectures, The Renin-Angiotensin System in Volume and Pressure Homeostasis, International Congress of Physiological Sciences Symposium, Helsinki, Finland	1989
Invited Symposia, Hypertension in the Aging Patient, American Geriatrics Society, Anaheim, California	1988
National and International Invited Seminars/Lectures, Hypertension Research Symposium, University of Tennessee, Memphis, Tennessee	1988
State/Local Invited Seminars/Lectures, Invited Lecture, Nephrology Research and Training Center, University of Alabama-Birmingham, Birmingham, Alabama	1988
State/Local Invited Seminars/Lectures, Invited Lecture, Abbott Laboratories, Research Division, Abbott Park, Illinois	1988
State/Local Invited Seminars/Lectures, Invited Lecture, Cardiovascular and Hypertension Center, The New York Hospital- Cornell Medical Center, New York, New York	1988
State/Local Invited Seminars/Lectures, Invited Lecture, Mayo Clinic Fellows' Visiting Faculty, Rochester, Minnesota	1988
National and International Invited Seminars/Lectures, The Intrarenal Circulation, American Society of Hypertension, New York, New York	1988
State/Local Invited Seminars/Lectures, Invited Lecture, DuPont Experimental Station, Wilmington, Delaware	1987
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology and Biophysics, University of Cincinnati School of Medicine, Cincinnati, Ohio	1987
State/Local Invited Seminars/Lectures, Invited Lecture, The University of Texas Health Science Center, School of Medicine, San Antonio, Texas	1987
National and International Invited Seminars/Lectures, Vasopressin, Fluid- Electrolyte Regulation, Second International Vasopressin Conference, Smugglers Notch, Vermont	1987
National and International Invited Seminars/Lectures, Hormones and Fluid Balance, International Union of Physiological Sciences, XXX International Congress, Vancouver, Canada	1986
Regional Invited Seminars/Lectures, Invited Lecture, Toronto Society of Hypertension, Toronto, Canada	1986
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin	1986
State/Local Invited Seminars/Lectures, Invited Lecture, Louisiana State University School of Medicine, Shreveport, Louisiana	1986
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology and Biophysics, The University of Tennessee Health Science Center, Memphis, Tennessee	1986
State/Local Invited Seminars/Lectures, Invited Lecture, DuPont Experimental Station, Wilmington, Delaware	1986
National and International Invited Seminars/Lectures, Neurohormonal Regulation of Water and Electrolyte Balance: Neural and Hormonal Control of Kidney Functions, American Physiological Society, New Orleans, Louisiana	1986
National and International Invited Seminars/Lectures, Physiological Role of the Intrarenal Renin-Angiotensin System, Federation of American Societies for Experimental Biology, Anaheim, California	1985
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology and Biophysics, Mayo Medical School, Rochester, Minnesota	1984
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, Texas College of Osteopathic Medicine, Fort Worth, Texas	1984
State/Local Invited Seminars/Lectures, Invited Lecture, Pfizer Central Research Group, Groton, Connecticut	1984
National and International Invited Seminars/Lectures, New Concepts of Blood Pressure Regulation, Federation of American Societies for Experimental Biology, St. Louis, Missouri	1984
Invited Symposia, The Adrenal Gland and Hypertension, Satellite Symposium of the International Society of Hypertension, Padova, Italy	1984
National and International Invited Seminars/Lectures, The Renal Origin of Hypertension: Progress over 50 Years, Council of High Blood Pressure Research of the American Heart Association, Toledo, Ohio	1984
State/Local Invited Seminars/Lectures, Invited Lecture, Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Melbourne, Australia	1983
Invited Symposia, The Kidney in Essential Hypertension, Alton Oscher Medical Foundation, New Orleans, Louisiana	1983
National and International Invited Seminars/Lectures, Intrinsic Regulation of Renal Hemodynamics, American Physiological Society, Cincinnati, Ohio	1981
National and International Invited Seminars/Lectures, Renal Hemodynamics, Eighth International Congress of Nephrology, Athens, Greece	1981
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, Michigan State University, East Lansing, Michigan	1979
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Hypertension, Cleveland Clinic, Cleveland, Ohio	1976

Honors, Awards, and Recognition

Arthur C. Guyton Award and Lecture, Association of Chairs of Departments of Physiology	2019
Carl G. Evers Basic Science Professor of the Year, UMMC Medical Students	2017
The Clifford V. and Drusilla R. Harding Lecture, Oakland University	2016
Basic and Clinical Sciences, for Guyton and Hall Textbook of Medical Physiology, 13th edition, British Medical Association	2016
Thomas G. Muldoon Memorial Lectureship, Medical College of Georgia, Augusta University	2016
Ray G. Daggs Award, American Physiological Society, “for distinguished service to the Society and to the science of physiology”	2016
Scholar Award, Distinguished Lecture Series, Texas A&M University	2016
2015 Distinguished Service Award, Association of Chairs of Departments of Physiology	2015
American Heart Association Award of Meritorious Achievement, for “For significant, long-lasting scholarly contributions, leadership and mentorship in the field of hypertension, including ten years as a highly successful Editor-in-Chief of the AHA journal Hypertension and 30 years as a vital leader for the Council on Hypertension, American Heart Association	2015
Visitante Ilustre de Facultad de Medicina, National University of Tucumán	2015
John D. Bower M.D. Distinguished Lectureship, University of Virginia School of Medicine, Division of Nephrology	2015
Joy Goodwin Distinguished Lectureship, Auburn University	2015
Distinguished Membership Award, for “Outstanding service and unusually distinguished contributions to experimental and clinical research in hypertension”, International Society of Hypertension	2014
2014 Professor of the Year Award (selected for outstanding contributions to research, education and service from over 50,000 faculty members in SEC schools), Southeastern Conference	2014
2014 Faculty Achievement Award, Southeastern Conference, University of Mississippi	2014
Distinguished Alumni Award and Inductee into Hall of Fame, Kent State University, College of Education, Health and Human Services	2013
Sir George Pickering Distinguished Lecture, British Hypertension Society	2013
Doctor Honoris Causa, Grigore T. Popa Universitatea De Medicina Si Farmacie, Iasi, Romania	2013
Excellence Award and Inductee into Mississippi Innovators Hall of Fame, Mississippi Technology Alliance	2012
Franz Volhard Award and Lecture for Outstanding Research, International Society of Hypertension	2012
Dr. Joseph Dvorkin Memorial Lecture, University of Alberta Cardiovascular Research Centre	2010
J.O. Davis Graduate Student Distinguished Lecturer, University of Missouri at Columbia, College of Medicine	2010
Lifetime Achievement Award, Inter-American Society of Hypertension	2009
Executive Council, International Society of Hypertension	2008
Presidential Lecture, Canadian Society of Hypertension	2007
Norman C. Nelson Order for Teaching Excellence, University of Mississippi Medical Center	2007
Mayerson/DiLuzio Memorial Lecture, Tulane School of Medicine	2006
British Medical Association Book Competition Award, for Textbook of Medical Physiology, 11th edition, British Medical Association, Basic and Clinical Sciences	2006
2005 Distinguished Achievement Award, American Heart Association, Council for High Blood Pressure Research	2005
Carl G. Evers "All Star" Professor, University of Mississippi Medical Center Student Body	2005
A. Ross McIntyre Award and Lecture, University of Nebraska Medical Center	2005
Executive Council and Treasurer, International Union of Physiological Science	2005
Lifetime Achievement Award, Consortium of Southeastern Hypertension Centers	2003
Carl G. Evers "All Star" Professor, University of Mississippi Medical Center Student body	2003
Michael J. Hack Memorial Lecture, Medical College of Wisconsin	2003
Editor-in-Chief, Hypertension Journal, American Heart Association	2002
Executive Scientific Council, International Society of Hypertension	2002
Novartis Award for Hypertension Research, Council for High Blood Pressure Research, American Heart Association	2002
President, Inter-American Society of Hypertension	2001
President, The American Physiological Society	2001
Visiting Professor in Basic Medical Sciences, Burroughs Wellcome Fund	2000
Richard Bright Award, American Society of Hypertension	2000
Chair, Council for High Blood Pressure Research, American Heart Association	1998
Ernest H. Starling Award and Distinguished Lecturer, The American Physiological Society	1998
Robert Tigerstedt Lifetime Achievement Award, Merck, Sharp & Dohme, International Society of Hypertension	1998
Pfizer Distinguished Lectureship, Clinical Research Institute of Montreal, Canada	1998
Billy S. Guyton Distinguished Professor, University of Mississippi Medical Center	1996
Editor-in-Chief, American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, The American Physiological Society	1996
Chair, Section Advisory Committee, The American Physiological Society	1996
Special Research Achievement Award, American Heart Association, Mississippi Affiliate	1996
Executive Council, American Society of Hypertension	1995
Frederick A. P. Barnard Distinguished Professor, University of Mississippi	1993
Treasurer and Executive Council, Inter-American Society of Hypertension	1993
John E. Whitney Memorial Award and Lecture, University of Arkansas	1992
Lewis K. Dahl Award and Lectureship, American Heart Association	1992
Chairman, Water & Electrolyte Homeostasis Section, The American Physiological Society	1991
Elected to Executive Council, The American Physiological Society	1991
Marion Young Scholar Award, The American Society of Hypertension	1988
Harry Goldblatt Award in Cardiovascular Research, Council for High Blood Pressure Research, American Heart Association	1984
Travel Grant Award, American Society of Nephrology, 9th International Congress of Nephrology, Los Angeles, California	1984
Travel Grant Award, American Physiological Society, 9th Congress of International Union of Physiological Sciences, Sidney, Australia	1983
Travel Grant Award, American Society of Nephrology, 8th International Congress of Nephrology, Athens, Greece	1981
Elected Fellow, Circulation Group, American Physiological Society	1980
Elected Fellow, Council for High Blood Pressure Research, American Heart Association	1980
Research Career Development Award, National Institutes of Health	1979
Ernest G. Spivey Research Award, American Heart Association, Mississippi Affiliate	1979
Research Service Award, National Institutes of Health	1975
Title IV Predoctoral Fellow Award, NDEA	1970
Award for scholastic achievement, Phi Delta Kappa	1968
Magna Cum Laude Graduate, Kent State University	1968
Deans List for academic achievement, Kent State University	1964

Committee Service

Vice Chancellor's Research Advisory Committee, Member	2013 - Present
MEDICAL CENTER-MARKETING, Member	2012 - 2014
MEDICAL CENTER-DIVERSITY, Member	2012 - 2014
Biomedical Research Grants Committee, Member	2012 - 2013
Search Committee for Obesity Center Director, Chair	2012 - 2013
MEDICAL CENTER-CANCER INSTITUTE INTERNAL ADVISORY, Vice Chair	2012 - 2013
Chief Development Officer Search Committee, Member	2011 - 2012
School of Pharmacy Research Awards Committee, Member	2011 - Present
UMMC/VA Affiliation Partnership Council, Member	2011 - 2014
Institutional Advisory Board, Mississippi Institute for the Improvement of Geographic Minority Health, Member	2010 - 2013
MEDICAL CENTER-MASTER PLANNING, Member	2009 - 2014
MEDICAL CENTER-MASTER PLANNING, Member	2009 - 2014
Pediatrics Chair Search Committee, Member	2009 - 2011
UMMC Vice Chancellor for Health Affairs Search Committee, Member	2009 - 2010
Committee for Selection of Billy S. Guyton Professors, Member	2009 - 2009
MEDICAL CENTER-SACS LEADERSHIP, Member	2008 - 2014
Institutional Enhancement Committee, Member	2007 - 2013
Conflict of Interest Committee, Member	2006 - 2013
MEDICAL CENTER-SPACE, Member	2006 - 2014
Search Committee for UMMC Cancer Insititute Director, Vice Chair	2006 - 2009
Facilities Strategic Planning Committee, Member	2006 - 2008
Human Resources Strategic Planning Committee, Member	2006 - 2008
Advisory Committee, Development Director	2006 - 2007
Science and Medicine Advisory Committee, Delta Health Alliance, Chair	2006 - 2007
MEDICAL CENTER-ANIMAL CARE AND USE, Ex-Officio Member	2005 - 2013
Biomedical Research Grants Committee, Chair	2005 - 2012
Cancer Institute Steering Committee, Vice Chair	2005 - 2013
Compliance Subcommittee for Research, Chair	2005 - 2013
MEDICAL CENTER-INSTITUTIONAL COMPLIANCE, Member	2005 - 2013
MEDICAL CENTER-LIBRARY FACULTY ADVISORY, Member	2005 - 2011
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Chair	2004 - 2004
MEDICAL CENTER-RESEARCH ADVISORY, Chair	2003 - 2013
Internal Advisory Board, Center of Excellence in Women's Health, Member	2003 - 2008
Search Committee for UMMC Development Director, Member	2003 - 2004
Internal Advisory Board, Center of Psychiatric Neurosciences, Member	2002 - Present
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Member	2000 - 2003
Dean's Graduate Research Award Selection Committee, Member	1998 - 2009
Dean's Graduate Scholarship Selection Committee, Member	1998 - 2009
Jackson Heart Study Scientific Directions Committee, Chair	1998 - 2003
Jackson Heart Study Protocol Development Committee, Chair	1998 - 1999
Steering Committee, Sesquicentennial Campaign, Member	1998 - 1998
Long Range Planning Committee, Member	1996 - 2013
Research Advisory/Development Committee, Member	1996 - 2013
Biomedical Research Grants Committee, Member	1996 - 2005
American Cancer Society Institutional Research Grants Committee, Member	1996 - 1996
Howard Hughes Institutional Research Grants Committee, Member	1996 - 1996
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Chair	1994 - 1994
SCHOOL OF DENTISTRY-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Member	1994 - 1998
Transfusion Medical Education Advisory Committee, Member	1990 - 2000
Anesthesiology Chair Search Advisory Search Committee, Member	1990 - 1990
School of Dentistry, Executive Faculty, Member	1989 - Present
SCHOOL OF MEDICINE-EXECUTIVE FACULTY, Member	1989 - Present
Basic Science Promotions Committee, Member	1989 - 2008
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Member	1989 - 1993
Neurology Chair Search Advisory Committee, Member	1989 - 1989
Surgery Chair Search Advisory Committee, Member	1989 - 1989
SCHOOL OF GRADUATE STUDIES IN THE HEALTH SCIENCES-GRADUATE COUNCIL, Member	1980 - Present

Other Service

Institutional Cost Reduction Task Force, Member	2009 - 2009
Pediatrics Chair Search Advisory Committee, Member	2009 - Present
Search committee for Obesity Center Director, Chair	2009 - Present
UMMC Vice Chancellor for Health Affairs Search Committee, Member	2009 - 2010
Committee for Selection of Billy S. Guyton Professors, Member	2009 - 2009
Institutional Quality Board, Member	2008 - 2009
Institutional Enhancement Committee, Member	2007 - Present
University of Mississipi Medical Center Research Foundation, Vice President	2006 - 2013
Search Committee for UMMC Cancer Institute Directo, Co-Chair	2006 - 2009
Facilities Strategic Planning Committee, Member	2006 - 2008
Human Resources Strategic Planning Committee, Member	2006 - 2008
Development Director Advisory Search Committee, Member	2006 - 2007
Science and Medicine Advisory Committee, Delta Health Alliance, Chair	2006 - 2007
Biomedical Research Grants Committee, Chair	2005 - Present
Compliance Subcommittee for Research, Chair	2005 - Present
Institutional Animal Care and Use Committee, Ex-Officio member	2005 - Present
Internal Advisory Board, Center of Excellence in Women’s Health, Member	2003 - 2008
Research Strategic Task Force, Chair	2003 - 2004
Search Committee for UMMC Development Director, Member	2003 - 2004
Research Council, Department of Medicine, Member	2001 - 2009
Dean's Graduate Research Award Selection Committee, Member	1998 - Present
Dean's Graduate Scholarship Selection Committee, Member	1998 - Present
Jackson Heart Study Scientific Directions Committee, Chair	1998 - 2003
Jackson Heart Study Protocol Development Committee, Chair	1998 - 1999
Steering Committee, Sesquicentennial Campaign, Member	1998 - 1998
Biomedical Research Grants Committee, Member	1996 - Present
Research Development Committee, Member	1996 - Present
American Cancer Society Institutional Research Grants Committee, Member	1996 - 1996
Howard Hughes Institutional Research Grants Committee, Member	1996 - 1996
Transfusion Medical Education Advisory Committee, Member	1990 - 2000
Anesthesiology Chair Search Advisory Search Committe, Member	1990 - 1990
Surgery Chair Search Advisory Committee, Member	1990 - 1990
Neurology Chair Search Advisory Committee, Member	1989 - 1989
AHA, Council for High Blood Pressure Research, Fellow	1980 - Present
Graduate Program in Physiology and Biophysics, Director	1980 - 1990
Participant, American Heart Association Research Summit	2012

Teaching Experience

611, Medicine, Course, Course Director, PHYS	2012
611, Medicine, Course, Course Director, PHYS	2011
611, Medicine, Course, Course Director, PHYS	2010
611, Medicine, Course, Course Director, PHYS	2009
611, Medicine, Course, Course Director, PHYS	2008
611, Medicine, Course, Course Director, PHYS	2007

Directed Student Learning

Supervised Research, Advised: Benjamin Pace	2011 - Present
Supervised Research, Advised: Corey Parish	2011 - 2011
Summer Research Volunteer, Advised: Ahmad Adi	2010 - 2010
Supervised Research, Advised: Ahmad Adi	2010 - 2011
Supervised Research, Advised: John Rushing	2010 - 2011
Supervised Research, Advised: Mark Davis	2009 - Present
Supervised Research, Advised: Benjamin Pace	2009 - 2010
Supervised Research, Advised: Mark Davis	2009 - 2010
Supervised Undergraduate Research, Advised: Jarrett Morgan	2009 - 2009
Advisor, Advised: Mark Davis	2008 - 2008
Advisor, Advised: Gray Wallace	2007 - 2007
Supervised Research, Advised: Nathan Freeman	2006 - 2011
Summer Research Program, Advised: John (Barr) Biglane	2006 - 2006
Summer Research Program, Advised: Lauren Cantwell	2006 - 2006
Thesis Advisor, Advised: Wendy Case	2006 - 2006
Supervised Research, Advised: John (Barr) Biglane	2006 - 2006
Supervised Research, Advised: Lauren Cantwell	2006 - 2006
Supervised Undergraduate Research, Advised: Joshua Lasseigne	2005 - 2005
Supervised Undergraduate Research, Advised: Tracie Perkins	2005 - 2005
Supervised Research, Advised: Brittany Penland	2005 - 2005
Supervised Research, Advised: John V. Roberts	2005 - 2005
Supervised Research, Advised: Lila Hudson	2004 - 2005
Supervised Undergraduate Research, Advised: Elizabeth Fowler	2004 - 2004
Supervised Undergraduate Research, Advised: Paul Brown	2004 - 2004
Supervised Research, Advised: Mary Alissa Willis	2004 - 2004
Supervised Undergraduate Research, Advised: Amel Mohamed	2003 - 2003
Supervised Undergraduate Research, Advised: Chiatne McFarland	2003 - 2003
Supervised Undergraduate Research, Advised: James Arthur Burwell II	2003 - 2003
Major Advsior, The Role of NA+-K+2CI- Cotransporter 1 in Cerebral Artery Contraction and in Neonatal Hypoxia-Ischemia Advised: Yun Dai	2003 - 2003
Dissertation Committee Member, Involvement of Mitogen- Activated Protein Kinase in the Pathogenesis of Cerebral Vasospasm Advised: Alexander Zubkov	2001 - 2001
Supervised Undergraduate Research, Advised: Allison Hailman	2000 - 2002
Supervised Undergraduate Research, Advised: Leigh Ammons	2000 - 2002
Supervised Undergraduate Research, Advised: Melanie Hand	2000 - 2000
Supervised Undergraduate Research, Advised: Megan Carlyle	1999 - 2000
Supervised Research, Advised: O. Barrett Jones	1999 - 2000
Dissertation Committee Chair, Role of Potassium in Protecting Against Arteriosclerosis and Neointimal Lesion Formation Advised: Ge Ma	1999 - 1999
Dissertation Committee Member, Advised: Jan ter Maaten	1999 - 1999
Supervised Undergraduate Research, Advised: Joel Paul Martin	1999 - 1999
Supervised Undergraduate Research, Advised: LeShawn McNair	1999 - 1999
Supervised Undergraduate Research, Advised: Monica Davis	1999 - 1999
Supervised Research, Advised: Matthew Verucchi	1999 - 1999
Supervised Undergraduate Research, Advised: Kim Anderson	1998 - 1999
Supervised Research, Advised: Glenn (Andy) Brien	1998 - 1999
Supervised Undergraduate Research, Advised: Lafarra Young	1998 - 1998
Supervised Research, Advised: Omar Logue	1998 - 1998
Supervised Research, Advised: Paul Kim	1998 - 1998
Dissertation Committee Member, Mechanisms of Insulin Hypertension in Rats Advised: Henry Keen	1997 - 1997
Supervised Research, Advised: William Hewitt	1997 - 1997
Supervised Undergraduate Research, Advised: Clifton R. Barker	1996 - 1997
Dissertation Committee Member, Interaction Between Intrarenal Nitric Oxide and the Renin-Angiotensin System in the Control of Kidney Function and Blood Pressure Advised: Christine Schnackenber	1996 - 1996
Dissertation Committee Member, Adaptation of Blood Vascular System to Maximum Metabolic Demand Advised: Jian Hang	1995 - 1995
Dissertation Committee Member, Renal and Cardiovascular Mechanisms of Obesity Hypertension Advised: Magdalena Alonso-Galicia	1995 - 1995
Supervised Research, Advised: Timothy Hopkins	1995 - 1995
Supervised Undergraduate Research, Advised: John Bradley Madden	1994 - 1996
Dissertation Committee Member, Endothelium-derived Nitric Oxide and Arterial Pressure Regulation Advised: Lufei Hu	1994 - 1994
Supervised Research, Advised: William Lee	1994 - 1994
Supervised Research, Advised: Angela Gardner	1993 - 1993
Supervised Research, Advised: David Harrison	1993 - 1993
Supervised Research, Advised: Michael Holman	1992 - 1992
Dissertation Committee Member, Role of Total Peripheral Resistance in the Long-Term Control of Arterial Blood Pressure and the Pathogenesis of Hypertension Advised: Min Huang	1991 - 1991
Dissertation Committee Member, Effects of Acute Hyperkalemia on Renal Hemodynamics and Renal Secretion in Intact Animals Advised: Huabao Lin	1990 - 1990
Dissertation Committee Member, Investigation of Canine Forelimb Arterial Vascular Pressure Gradients with Reference to the Ability of Peripheral Measurement Sites to Estimate the Parameters of the Central Aortic Pressure Advised: A. William Paulsen	1989 - 1989
Dissertation Committee Member, Adrenergic Regulation of Renin Release and the Role of Angiotensin II in Mediating the Renal Actions of Norepinephrine Advised: Hun Mo Yang	1989 - 1989
Dissertation Committee Member, Role of the Transvascular Fluid Flux and Lymph Flow in Extracellular Fluid Volume Regulation During Vasoconstrictor and Volume-loading Hypertension Advised: Jorge Valenzuela-Williams	1989 - 1989
Dissertation Committee Member, Effects of Selective B2-Agonist on Circulatory Control Mechanisms in Dogs Advised: Bahij Nuwayhid	1987 - 1987
Major Advisor, Role of the Renal Nerves in the Long Term Control of Renal Hemodynamics and Electrolyte Excretion Advised: H. Leland Mizelle	1987 - 1987
Dissertation Committee Member, Analysis of the Cardiovascular Effects of Arginine Vasopressin in Dogs Advised: Udom Tipayomontri	1984 - 1984
Dissertation Committee Member, Baroreceptor Gain, Arterial Pressure and Heart Rate in Arterial Baroreceptor Denervated and Spontaneously Hypertensive Rats Advised: Ann Dent	1983 - 1983
Major Advisor, Control of Renal Hemodynamics, Electrolyte Excretion and Arterial Pressure: Role of the Kallikrein-Kinin System Advised: Joey Granger	1983 - 1983
Dissertation Committee Chair, Reactive and Exercise Hyperemic During High Levels of Adenosine Infusion Advised: Robert Hester	1982 - 1982
Dissertation Committee Member, Oxygen Consumption, Heart Rate, and Subjective Rating Under Conditions of Relaxation and Active Coping Advised: James Hollandsworth	1982 - 1982
Dissertation Committee Member, Evaluation of Reflex Control of Arterial Pressure by Sinusoidal Blood Volume Changes in Baroreceptor Denervated and Baroreceptor Innervated Dogs Advised: David Brown	1981 - 1981
Dissertation Committee Member, The Interaction of Volume and Osmoreceptors in the Control of Plasma Vasopressin, Body Fluid Volumes, and Electrolytes Advised: Edmund Quillen	1981 - 1981
Dissertation Committee Member, Experimental Aldosterone Hypertension Advised: Yi-Jen Pan	1979 - 1979
Dissertation Committee Member, The Pulmonary Circulation: Studies on Alveolar Hypoxia and Vascular Smooth Muscle Metabolism Advised: Richard Parker	1978 - 1978
Supervised Research, Advised: Beth Mitcheltree-Miller
Supervised Research, Advised: Robert Meacham III
Supervised Research, Advised: William N. Dixon
Supervised Research, Advised: John E. Ammons
Supervised Research, Advised: Robert Stewart
Supervised Research, Advised: Andrew C. Brown
Supervised Research, Advised: Lee E. Herring
Supervised Research, Advised: Melynda Cummins
Supervised Research, Advised: Jennifer DeCrane
Supervised Research, Advised: S. Keith Rushing
Supervised Research, Advised: Ava H. Bell
Supervised Research, Advised: George M. Thurber
Supervised Research, Advised: Anthony E. Daniels
Supervised Research, Advised: Aubrey L. Scott
Supervised Research, Advised: Celia Lauren Morse
Supervised Research, Advised: Douglas N. Packer

Fellows supervised

University of Mississippi Medical Center Department of Physiology, Training Faculty, 34 fellows supervised, Hall Lab

01/1976 - Present

Extramural, Role of Renal Nerves in Obesity-Induced Hypertension, St. Jude Medical, Inc.	07/2010 - 06/2012
Extramural, Non-Invasive Hemodynamic Monitoring, National Institutes of Health	06/2010 - 07/2012
Extramural, Cardiovascular Dynamics and Their Control (minority supplement award), National Institutes of Health	03/2009 - 11/2012
Extramural, Canadian Institutes of Health Research Fellowship Award for Dr. Shereen Hamza, Canadian Institutes of Health	01/2009 - 12/2012
Extramural, Mechanisms in Obesity-Induced Renal Injury - postdoctoral fellowship award for Shankar Munusamy, American Heart Association	01/2009 - 12/2011
Extramural, Cardiovascular Dynamics and their Control, National Institutes of Health	12/2008 - 11/2013
Extramural, Blockade of Soluble Epoxide Hydrolase in Obesity Hypertension, ARETE Therapeutics	08/2008 - 07/2009
Extramural, Chronic Metabolic Effects of Blocking Soluble Epoxide Hydrolase, ARETE Therapeutics	06/2008 - 07/2009
Extramural, 11B-HSD1 inhibition in hypertension, Merck & Company, Inc.	02/2008 - 01/2009
Extramural, Mechanisms of Obesity-Induced Renal Injury - postdoctoral fellowship award for Elizabeth Brandon, National Institutes of Health	01/2007 - 12/2010
Extramural, Distinguished Lecture Series, Robert M. Hearin Support Foundation	09/2006 - 08/2012
Extramural, Physician Scientist Training Program, Robert M. Hearin Support Foundation	09/2006 - 08/2012
Extramural, Jackson Cardiovascular-Renal Meeting, Robert M. Hearin Support Foundation	09/2006 - 08/2009
Extramural, Medical Research Scholars Program, Robert M. Hearin Support Foundation	07/2006 - 06/2012
Extramural, Postdoctoral Fellowship Program, Robert M. Hearin Support Foundation	07/2006 - 06/2009
Extramural, Cardiovascular-Renal Meeting, Robert M. Hearin Foundation	01/2006 - 12/2010
Extramural, Postdoctoral Fellows Training Program, Robert M. Hearin Foundation	01/2006 - 12/2010
Extramural, Blockade of Soluble Epoxide Hydrolase-a Novel Anti-hypertensive Therapy, ARETE Therapeutics	01/2006 - 12/2007
Extramural, Novartis Institutes for Biomedical Research, Novartis	07/2005 - 07/2008
Extramural, Jackson Heart Study, National Institutes of Health	01/2005 - 12/2013
Extramural, Pfizer Global Research & Development, Pfizer	01/2004 - 12/2006
Extramural, Role of the Melanocortin-4 Receptor in Obesity Hypertension - postdoctoral fellowship award for Lakshmi Tallam, American Heart Association	01/2004 - 12/2006
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health	01/2003 - 12/2008
Extramural, Role of Melanocortin & Sympathetic Nervous Systems in Mediating the Actions of Leptin in Type-1 Diabetes - postdoctoral fellowship award for Alexandre daSilva, American Heart Association	01/2003 - 12/2005
Extramural, Endocannabinoids in Obesity, Merck & Co, Inc.	01/2003 - 12/2004
Extramural, The Renin-Angiotensin-Aldosterone System and Obesity-induced Hypertension, Pharmacia Co.	01/2002 - 12/2002
Extramural, Molecular Genetics Core Facility, Department of Health and Human Services	01/2001 - 12/2002
Extramural, Jackson Heart Study, National Institutes of Health	01/1999 - 12/2005
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health	01/1998 - 12/2003
Extramural, Cardiorenal Adaptation in Obesity Hypertension - NRSA for Jeff Henegar, National Institutes of Health	01/1998 - 12/2001
Extramural, Grant for Center for Excellence in Cardiovascular-Renal Research, Renal Care Foundation	01/1998 - 12/2000
Extramural, Jackson Heart Study, Phase I Feasibility Study, National Institutes of Health	01/1997 - 12/1999
Extramural, Grant for Center for Excellence in Cardiovascular-Renal Research, Renal Care Foundation	01/1996 - 12/1997
Extramural, Role of Amylin in Mediating Cardiovascular Changes in Obesity, Amylin Pharmaceuticals	01/1996 - 12/1996
Extramural, Neurohumoral Mechanisms of Obesity Hypertension - NRSA for Dion Zappe, National Institutes of Health	01/1994 - 12/1996
Extramural, Obesity-Induced Hypertension: Role of the Sympathetic Nervous System & Renin-Angiotensin System - postdoctoral fellowship for Dion Zappe, American Heart Association, Mississippi Affiliate	01/1994 - 12/1996
Extramural, The Renin-Angiotensin System and Obesity-Induced Hypertension, Bristol-Myers Squibb Co.	01/1994 - 12/1996
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health	01/1993 - 12/1999
Extramural, Physiology Graduate Fellowship Training Grant, GLAXO	01/1993 - 12/1996
Extramural, Chronic Renal, Hormonal, and Blood Pressure Effects of a New Angiotensin Converting Enzyme Inhibitor During Chronic Congestive Heart Failure, Ciba-Geigy Corporation	01/1990 - 12/1990
Extramural, Calcium Homeostasis in Hypertension, National Institutes of Health	01/1989 - 12/1992
Extramural, Hormonal Control of Renal Function, National Institutes of Health	01/1988 - 12/1994
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health	01/1988 - 12/1993
Extramural, Chronic Renal Actions of Atrial Natriuretic Factor, National Institutes of Health	01/1988 - 12/1991
Extramural, Role of Hyperinsulinemia in Obesity Hypertension, American Heart Association	01/1988 - 12/1990
Extramural, Young Scholar Award, Marion Laboratories	01/1988 - 12/1988
Extramural, Blood Pressure and Renal Function in Hyperinsulinemia, National Institutes of Health	01/1987 - 12/1993
Extramural, Role of Hyperinsulinemia in Hypertension Associated with Obesity, National Institutes of Health	01/1987 - 12/1987
Extramural, Comparison of the Chronic Renal and Blood Pressure Effects of a New Renin Inhibitor (CP-71362) With a Converting Enzyme Inhibitor in Conscious Dogs, Pfizer Central Research	01/1986 - 12/1986
Extramural, Renal and Hormonal Mechanisms of Blood Pressure Control, National Institutes of Health	01/1984 - 12/1987
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health	01/1983 - 12/1988
Extramural, Neural Control of the Kidney, National Institutes of Health	01/1983 - 12/1985
Extramural, Hormonal Control of Renal Function, National Institutes of Health	01/1982 - 12/1987
Extramural, Angiotensin and Neural Control of Kidney, Mississippi Heart Association	01/1982 - 12/1984
Extramural, Intrarenal Role of Renin Angiotensin System, Mississippi Heart Association	01/1980 - 12/1982
Extramural, Hormonal Control of Renal Function, National Institutes of Health	01/1978 - 12/1984
Extramural, Hormonal Control of Renal Function, National Institutes of Health	01/1978 - 12/1982
Extramural, Intrarenal Role of the Renin-Angiotensin System, Mississippi Heart Association	01/1978 - 12/1980
Extramural, Role of Adrenal Cortical Hormones in Regulating Renal Function, Kidney Foundation of Mississippi	01/1978 - 12/1978
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health	01/1977 - 12/1982
Extramural, Role of the Renal Medulla in the Control of Blood Pressure, Mississippi Heart Association	01/1976 - 12/1977
Extramural, Peripheral Vascular Control During Hemorrhage, National Institutes of Health	01/1975 - 12/1978

John E. Hall

Education

Current Positions

Academic Appointments or Other Previous Appointments

Sponsored Program Funding

Publications

Biography

Journal Article

Review Article

Abstracts

Book Chapter

Book

Editorial Commentary